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ABSTRACT OF DISSERTATION 
 
 
NANOPARTICLE BEHAVIOR IN BIOLOGICAL GELS AND BIOFLUIDS:  
THE IMPACT OF INTERACTIONS WITH CHARGED BIOGELS AND THE 
FORMATION OF PROTEIN CORONAS ON NANOPARTICLES 
	
With the rapid growth of nanotechnology, situations where nanomaterials will 
interact with biological systems will unquestionably grow. Therefore, it is increasingly 
understood that interactions between nanomaterials and biological environments will play 
an essential role in nanomedicine. Biological polymer networks, including mucus and the 
extracellular matrix, serve as a filter for the exchange of molecules and nanoparticles. 
Such polymer networks are complex and heterogeneous hydrogel environments that 
regulate transport processes through finely tuned particle-network interactions. In 
chapters 3 and 4, we investigate the role of electrostatics on the basic mechanisms 
governing the diffusion of charged molecules inside model polymer networks by using 
fluorescence correlation spectroscopy (FCS). In chapter 3, we show that particle transport 
of charged probe molecules in charged hydrogels is highly asymmetric and that the 
filtering capability of the gel is sensitive to the solution ionic strength. Brownian 
dynamics simulations are in quantitative agreement with our experimental result. In 
chapter 4, we focus on hyperbranched cationic dendrimer macromolecules 
(polyamidoamine, PAMAM) which differ from probes in size, charge density and chain 
flexibilities.  Our results show PAMAM has strongly reduced mobility in like charge gels 
and greatly enhanced apparent diffusivity in oppositely charged gels. Further studies with 
salt suggest that the oppositely charged polymer network acts as a giant counterion 
enhancing the mobility of PAMAM by changing its conformation to a more compacted 
state. 
 
Due to their large surface areas, nanomaterials in biological fluids are modified by 
adsorption of biomolecules, mainly proteins, to form so called “protein coronas”.  These 
coronas ultimately define the biological identity of the nanoparticles and dictate the 
interactions of cells with the protein-NP complex. We have studied the adsorption of 
human transferrin and bovine serum albumin on the surface of sulfonated polystyrene 
nanoparticle. In chapter 5, we show the formation of multi-layered protein coronas and 
compare to established adsorption models.  In addition we followed for the first time the 
protein binding kinetics as a function of pH and salt. Through these studies, we aim to 
	 iii	
gain quantitative knowledge of the dynamic rearrangement of proteins on engineered 
nanomaterials.  
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Chapter 1 Background and introduction 
 In recent years, significant effort has been devoted to the field of nanotechnology in 
which functional structures are designed at the atomic or molecular scale and constructed 
with at least one characteristic dimension measured in nanometers. Nanoparticles (NPs) 
often demonstrate unique physical and chemical properties compared to bulk materials, 
and hence been therefore extensively investigated for a variety of biological and 
biomedical applications.1  
1.1 Advantages of nanoparticles over bulk materials 
 In general, engineered nanomaterials (ENMs) are materials molecularly designed 
with at least one dimension ≤ 100 nm to produce new materials, structures and devices.2 
There are two major reasons why many nanoscaled materials have unique properties 
compared to bulk materials.  First, nanoparticles have a very large surface area to mass 
(volume) ratio resulting in a significant increase in the percentage of atoms at the surface 
of a material. For example, if we compare the same mass of carbon in either 60 nm or 60 
µm particle form, the nanoparticles would have 1000 times the surface area the 
microparticles resulting in the surface area for chemical reaction being enhanced 1000-
fold.3 The large functional surface areas inherent to nanoparticles enable them to very 
efficiently bind, adsorb and carry other compounds, such as drugs, probes or proteins, 
while maintaining the small size required to successfully penetrate physiological barriers 
and translocate within living organisms4. The second main reason for the unique 
properties observed in nanomaterials is due to new quantum effects that arise due to the 
particle size.  When the size of a particle is decreased into the nanometer scale, 
comparable to the wavelength of electrons, the motion of randomly moving electrons in 
the material is restricted to specific energy levels (discreteness) giving rise to quantum 
confinement effects.5 This phenomenon can give rise to unique optical and electronic 
properties in nanoparticles that are inaccessible in bulk materials. An example of a class 
of materials that clearly exploits quantum effects is quantum dots (QDs) — synthesized 
semiconductor nanomaterials. By simply changing the size of CdSe quantum dots, their 
emission can be effective tuned from red (520 nm) to the near infrared (NIR) (700-900 
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nm).6 This ability to molecularly manipulate properties increases the possibilities for 
designing tailored QDs for specific imaging, cellular tracking and diagnostic 
applications.7  
 There are many types of nanoparticle platforms with differing size, shape, 
composition and functionality under investigation for use in vivo. Most commonly, 
nanostructures are engineered to either carry therapeutics for safe delivery to targeted 
sites or use as a contrasting agents for various imaging techniques.8 Nanoparticles 
commonly consist of inorganic materials, including metal, metal oxides and 
semiconductors, or a wide range of organic particles such as polymeric particles, 
liposomes, and dendrimers.1-2, 9 These materials can be further chemically modified to 
create desirable surface properties like charge, hydrophobicity or incorporation of 
targeting agents for specific applications.  Conceptually, such flexibility in designing and 
modularity enables nanoparticles to be tailored into highly versatile therapeutic agents 
capable of performing complex functions within physiological systems (Figure 1.1).9 
Figure 1.1 Illustration of different type of nanoparticle platforms. Nanoparticles can be 
modularly assembled from different materials composition with different physical and 
chemical properties and functionalized with a myriad of ligands for biological targeting.9  
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1.2 Nanoparticles in biological applications 
	
1.2.1 Nanoparticles in biosensors 
      A biosensor is an analytical device with biological recognition elements used to 
measure biological processes or physical changes.10 The unique physicochemical 
properties of nanomaterials make them promising candidates for designing new and 
improved biosensors tailored to address specific analytical needs. Different kinds of 
nanoparticles may play different roles in sensing systems based on their unique 
properties. Generally, metal nanoparticles act as “electronic wires” for electron transfer 
enhancement or as catalysts to increase electrochemical reactions based on their excellent 
conductivity and catalytic properties. Oxide nanoparticles are often used in the 
immobilization of biomolecules due to their biocompatibility, while semiconductor 
nanoparticles are often used as labels or tracers for electrochemical analysis.11-12  
 As an example, gold nanoparticles are particularly popular for biosensor research 
because of their intriguing surface chemistry.11 One method of using gold nanoparticles 
as signal transduction amplification tags is the bio-barcode method developed by the lab 
of Dr. Chad Mirkin.13-14 This is an ultrasensitive method for DNA and protein detection 
and shows great promise for the diagnosis of genetic and pathogenic diseases.15-16 In the 
general procedure of bio-barcode detection, gold nanoparticles are modified with single-
strand oligonucleotides that hybridize with target sequences resulting in not only a 
binding but also a controlled aggregation of Au-oligonucleotide probes. Based on the 
unique optical property of the gold nanoparticles, the color of the solution changes from 
red to blue when the interparticle distance is decreased to less than the diameter of gold 
nanoparticles.17-18 Therefore the signal of hybridization process can be assessed by this 
simple colorimetric sensing strategy. Compared with traditional radioactively labeled 
probe detection methods, this method has no problem with sample disposal and no 
requirement of specially trained personnel.13 In addition, this method allows for the 
detection of oligonucleotides at sub-picomolar level without the assistance of polymerase 
chain reaction (PCR).19  
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1.2.2 Nanoparticles in bioimaging  
 Medical imaging techniques, such as magnetic resonance imaging (MRI), optical 
imaging (OI), computed tomography (CT), ultrasound imaging (USI), and positron 
emission tomography (PET), create visual presentation of in vitro and in vivo biological 
specimens and thus play critical roles in disease detection, prognosis, and treatment 
planning.1, 8 Engineered nanomaterials, especially inorganic nanoparticles with their 
intrinsic quantum mechanical properties, have proven to be remarkable contrast agents 
and are used in various imaging techniques. First, nanoparticles improve the sensitivity of 
imaging due to their large surface area to volume ratio thus allowing for the loading of a 
large amount of imaging agents in a single dosing. Second, nanoparticles are able to 
accumulate in tumor tissue more efficiently than they do in normal tissues due to the 
enhanced permeability and retention (EPR) effect resulting in an increasing of the local 
concentration of contrast agent.20 This selective accumulation of nanoparticles in tumor 
cells makes significant improvements on cancer diagnosis and treatment.21 In addition, 
the high capacity for nanoparticle chemical modification enables them to be engineered 
to deliver several different types of imaging agents simultaneously. Development of 
multifunctional nanoparticles allows for more reliable and accurate detection of disease 
sites through synergetic multimodal imaging.22 For instance, there are currently dual-
functional nanoparticles with integration of optical and magnetic properties for 
simultaneous imaging by OI and MRI.23  
 One of the nanoparticle platforms with outstanding optical properties, quantum dots 
(QDs), have been facilitating the development of in vivo optical imaging.24 Compared to 
conventional fluorophores, QDs have advantages like high quantum yields, broad 
absorption spectra, narrow and size-tunable emission spectra, and strong resistance to 
photobleaching.24-26 Since emission spectra of QDs can be tuned into the NIR region 
(700-900 nm), the autofluorescence from tissues can be greatly reduced providing a clear 
target window for in vivo optical imaging.27 As an example, Cai et al. reported the 
targeting and imaging of tumor vasculature in living mice by using arginine-glycine-
aspartic acid (RGD) peptide-conjugated NIR QDs.28 
	 5	
1.2.3 Nanoparticles in drug delivery 
 The efficient delivery and release of therapeutics to the target site remains a crucial 
challenge in the treatment of many diseases.29 Various nanoparticle-based drug delivery 
vectors are proposed to improve the therapeutic outcome based on one or more of the 
following aspects:30 (1) To improve the bioavailability of poorly water-soluble drugs; (2) 
To protect drug molecules from undesirable biodegradation; (3) To transport drugs across 
tightly controlled epithelial and endothelial barriers; (4) To deliver drugs at a specific 
location with controlled release; (5) To reduce the toxicity of drugs while maintaining the 
therapeutic effect; (6) To deliver more than one type of drug or therapeutic modality for 
combination therapy; (7) To visualize the location of drug delivery by integrating 
therapeutic agents and imaging modalities.31  
 
 In nanoparticle-based drug delivery, drug molecules need to first be either covalently 
or non-covalently bound to nanocarriers. The nanocarriers are required to efficiently 
transfer drug molecules to the target site and ensure their stability and functionality 
during the transport. Targeted drug delivery can be approached from two strategies: 
active or passive targeting.32 Active targeting requires carriers to be attached with 
customized ligands (antibodies, peptides, aptamers or small molecules) to specifically 
bind to the receptors on target cells. For example, folic acid or methotrexate are 
selectively used for cancer treatment because the folate receptors are highly expressed on 
the cancer cell surface but not on normal cells.33 In the case of passive targeting, selective 
accumulation of carriers in the targeted cells or tissues is based on physicochemical or 
pharmacological factors. One of the unique pathophysiological characteristics of tumor 
vessels, the EPR (enhanced permeability and retention) effect enables nanoparticles to 
accumulate preferentially in tumor tissues.34 After the carriers reach the target cells or 
tissues, drug molecules then need to be released from the nanoparticles. This releasing 
process can be triggered either externally by heat or light or exploit the local chemical 
environment of the target, such as pH, hydrophobicity or concentration of specific ions.2 
In a more advanced delivery system, multifunctional nanoparticles are able to perform as 
imaging agents and therapeutic agents simultaneously. Successful integration of these 
different modalities in one delivery system, a “super” particle, may enable simultaneous 
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diagnosis, therapy and monitoring of therapeutic response.35 
1.3 The challenge of applications of nanoparticles in biomedicine  
 As described above, nanoparticles provide tremendous potential advantages in drug 
delivery, discovery of biomarkers and molecular diagnostics. The growing use of 
nanotechnology in biological and biomedical applications also brings safety concern to 
human health. The unique properties of nanoparticles which make them so attractive in 
medicine, may also contribute to the toxicological profile of nanoparticles in biological 
systems.36 For example, the nanosize of these particles potentially allows them to cross 
various biological barriers within the body and translocate to different compartments of 
organs, tissues or cells.  For example, while nanoparticles with the potential ability to 
cross the blood-brain-barrier (BBB) may open new means for the diagnosis and treatment 
of brain diseases, at the same time, nanoparticles penetrating the BBB may also cause 
unintended detrimental health effects on the brain and nervous system not seen presently 
with conventional drug delivery systems. 
 As nanotechnology rises, the opportunities for biological systems to interact with 
engineered nanomaterials, intentionally or unintentionally, will only increase. There is a 
growing concern therefore about how these nanomaterials behave once inside the body. 
The potential toxicity of certain nanoparticles may result in the generation of disorders 
such as inflammation, immunoreaction, or even cancer.37 The mechanisms of these 
effects are not well understood yet, but might be due to concentration-dependent side 
effects like cell injury or death or the undesirable accumulation in vital organs like liver, 
lungs or kidneys.37-39 In many nanoparticle-based drug delivery studies, a reduction of 
toxicity is obtained from the optimization of the drug molecules, whereas the potential 
toxicity caused by nanocarriers is often not in consideration.4 To date, understanding of 
the possible reactivity of nanoparticles in vivo and the basics of the interaction between 
nanoparticle and biological systems has been lacking yet is desperately needed for 
developing safe nanomaterials for biomedical applications.4, 40 
1.4 Research motivation and introduction to specific projects  
 It is obvious that for effective diagnosis or therapy a sufficient concentration of 
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nanoparticles and their functional surface chemistry need to be maintained.  To balance 
the biocompatibility and toxicity of the nanoparticles, we are interested in the study of the 
transport processes and biodistribution of nanoparticles in biological systems. Extensive 
studies have been done to characterize the physicochemical characteristics of 
nanoparticles themselves, however little is known about how these nanoparticles interact 
with biomacromolecules inside living systems which ultimately determines the destiny, 
distribution and bioaccumulation of the nanoparticles in vivo.  
 In the first two projects described here, we have studied the transport of charged 
probe molecules and charged, hyperbranched dendrimer macromolecules in neutral and 
charged biological hydrogels, in chapter 3 and 4 respectively. Recent studies have shown 
that the movement of particles in biogels, such as mucus, the extracellular matrix or the 
nuclear pore complex, can depend on the charge and size of the particles as well as the 
properties of the network itself.41-42 There is growing evidence that more complex 
interactions between the diffusing particle and the polymer matrix result in a more 
intricate selection process called interaction filtering, which allows some particles to pass 
through the network and others to be kept out.43-45 Particle-gel interactions in vivo may 
include many specific and nonspecific interactions, such as electrostatics, hydrophobic 
interactions, and chemical binding. To gain insight into these complex interactions, it is 
instructive to examine transport properties within simpler model systems such as water-
soluble polymer networks.  In chapter 3, we examine the transport properties of charged 
probe molecules in neutral and charged hydrogels.  Our results show that the probe 
transport in the charged hydrogels is highly asymmetric, with diffusion slowed down 
much more by electrostatic attraction than by repulsion. In addition, we show that the 
filtering capability of the hydrogel is sensitive to the solution ionic strength in 
quantitative agreement with Brownian dynamics simulation results. In chapter 4, we 
examine the diffusion of hyperbranched charged PAMAM dendrimer molecules within 
neutral and charged hydrogels.  As expected, diffusion of the PAMAM is hindered in 
neutral gels due to sterics.  Like the probe molecules, diffusion is even more strongly 
hindered in gels with the same charge (electrostatic repulsion).  This reduced transport of 
charged particles in like-charged networks is most likely due to a “caging” of the 
molecules due to the repulsive particle-network electrostatics.  Surprisingly when the 
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dendrimer and hydrogel have opposite charge, i.e. electrostatic attraction, the apparent 
mobility of the dendrimer increases significantly even surpassing the diffusion coefficient 
of the dendrimer in pure water.  Additional experiments examining the effects of added 
salt suggest the flexible dendrimers are able to undergo large conformational change 
resulting in a significantly more compacted particle at high ionic strength with a smaller 
diffusion coefficient. Our results suggest the oppositely charge hydrogel acts like a large 
counterion resulting in the dendrimer compacting within the network even without 
additional salt present. Taken together these studies reveal the essential role of 
electrostatic interaction in governing the nanoparticle transport in biological hydrogels 
and may lead to better understanding of how the biological barriers filter and control the 
exchange of molecules between organelles and cells and their environments. 
 When nanoparticles are introduced into biological fluid, the large surface area of the 
nanoparticles (NPs) result in the particles being rapidly modified via the adsorption of 
biomolecules such as proteins or lipids.  The end result is a nanoparticle coated with a 
“corona” of biomaterial. This corona formation affects the biodistribution of 
nanoparticles and their fate in vivo by influencing the biological response of the particle 
with the body. Understanding the fundamental processes of protein corona formation is 
therefore necessary for control and manipulation of protein binding and engineering of 
nanoparticles with favorable bioavailability.   In Chapter 5, we examined the interaction 
of proteins with polymeric nanoparticles by fluorescence correlations spectroscopy (FCS).  
Specifically, we studied human transferrin (Tf) and bovine serum albumin (BSA) 
adsorption on 50 nm diameter sulfonated polystyrene (PS) beads.  FCS analysis uniquely 
allows us to quantitatively determine both the size and number of fluorescently labeled 
particles in solution. Appropriate labeling of the protein or nanoparticle, allows for 
sensitive real-time monitoring of the assembly of protein-NP complexes over time under 
a variety of conditions. By detecting size and changes in free and bound protein fractions, 
FCS allows for the quantitative determination of the absolute number of bound proteins 
in the corona and their exchange dynamics in body fluid.  Our results show significant 
differences in the resulting thickness of the corona between Tf-PS and BSA-PS 
complexes at the same protein/NP stoichiometry ratios.  Kinetic studies show the binding 
rates of Tf-PS are strongly affected by the solution pH which BSA-PS are significantly 
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less affected. The solution ionic strength for both protein-PS systems does not show a 
strong dependence of the binding rate; however, the binding affinity is highly dependent 
on salt. Such studies may lead to a deeper understanding of how local physicochemical 
properties govern the protein corona formation and complete the pharmacokinetic 
profiles of nanoparticles. 
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Chapter 2 Fluorescence Correlation Spectroscopy 
 
 To study the dynamics of nanoparticle transport in biological environments, we 
employed fluorescence correlation spectroscopy (FCS), which offers non-invasive and 
direct monitoring of chemical kinetics on a single-molecule level. FCS is able to extract 
dynamic information from observing the intensity fluctuations of small ensembles of 
fluorescent molecules in thermal equilibrium. The fluorescence fluctuations are 
autocorrelated to quantify the characteristic diffusion time of labeled molecules and have 
been shown to provide information on important molecular properties such as particle 
concentration, translational and rotational diffusion, chemical kinetics, binding reactions, 
and molecular aggregation in solution as well as the characteristic lifetimes of the 
fluorophore.46-48 
 Due to the focused laser beam and confocal pinhole setup, FCS has high spatial and 
temporal resolution that allows extremely low sample consumption and short sampling 
time. Compared to other techniques commonly used to measure the dynamics of 
nanoparticle diffusion, FCS has unique advantages.47-49 FCS is a technique that evolved 
from dynamic light scattering (DLS). FCS is able to measure the size distribution profile 
of small particles and their states of motion in solution by analyzing the scattering light.50 
While DLS is very sensitive to contaminants such as dirt, FCS measures fluctuations only 
of fluorescently labeled particles and has less problems with contaminants. Another 
popular technique, Fluorescence Recovery After Photobleaching (FRAP), measures the 
diffusion rate by monitoring fluorescence recovery within photobleached spots.51-52 
Limitations of FRAP include not being able to measure the concentration, inability to 
distinguish between single and multiple component diffusion, and the need for a high 
intensity laser that can cause photodamage to some biological samples like living cells. 
Single-particle tracking (SPT) obtains transport parameters by imaging the pathway of 
single molecule. The analysis, however, can be complicated and severely affected by 
noise. The image noise affects the number of obtained trajectories as well as the accuracy 
of the particle coordinates.53 Due to the shortcoming of other methodologies, FCS has 
quickly become a favorable method to probe the molecular diffusion and transport 
	 11	
processes of particles in vitro and in vivo for biophysical, cell biology and analytical 
chemical research.  
 
2.1 History of FCS 
 FCS was devised in 1972 by D. Magde, E. Elson and W.W. Webb. One of the first 
applications of FCS was to measure the kinetics of the binding of a fluorescent molecule 
(ethidium bromide, EtBr) to double stranded DNA.54 EtBr is a small dye molecule whose 
fluorescence quantum yield increases 20 times after it intercalates between DNA base 
pairs. Therefore the binding-debinding process caused the fluorescence fluctuation that 
allowed accessing the dynamic parameters of this equilibrium reaction.54-55 
 
 In the early 1970s, the original FCS setup had a laser excitation of 6 kW cm−2 at 514 
nm. The scattered excitation light was filtered by a saturated K2Cr2O7 solution, and 
fluorescence was collected by a parabolic reflector then detected with a photomultiplier 
tube.55 Nowadays, excitation light can be conveniently and efficiently separated from 
fluorescence light by using dichroic mirrors and interference filters. In the 70’s, the 
dimension of observation volume of FCS was 5 mm transversally and 150 mm 
longitudinally and about 104 molecules were in the field of view.55 These parameters are 
several orders of magnitude larger compared to a typical modern FCS setup. Although 
the original FCS had relatively low sensitivity, it proved that chemical kinetics were 
assessable through the analysis of fluorescence fluctuation.  
 
 FCS was not widely applied to biotechnology or biological sciences until the spatial 
resolution was greatly enhanced in the early 1990’s. In 1993，Rigler et al first 
introduced the confocal illumination scheme in FCS which used a pinhole in the 
detection path to minimize the scattered light from background.56 With the adaption of a 
confocal setup, the signal to noise ratio dramatically increased. With this increased 
sensitivity, FCS was finally capable of monitoring concentrations down to the nanomolar 
range and conducting the measurements on the single-molecule level.  
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 In the 21st century, with the integration of diverse types of optical approaches, such 
as dual-color cross correlation and multi-photon excitation, FCS is able to describe 
multiple dynamic processes occurring in complex environments and has been effectively 
applied to both in vitro and in vivo systems.49, 57-58 Nowadays FCS is becoming a versatile 
tool used to screen drug molecules; investigate the conformational changes in 
biomolecules; evaluate diffusion inside cells and on the cell membrane; and characterize 
adsorption kinetics and enzyme kinetics.59 
 
2.2 Theory of FCS 
	
2.2.1 Autocorrelation 
 FCS records and correlates the spontaneous fluorescence signal fluctuation to reveal 
the dynamics in the sample under study. Fluctuations in fluorescence signals are caused 
by fluorophores moving in and out of the observation volume by Brownian motion and 
also can be induced by the photodynamic property change from molecules during dwell 
time.60 
 
 The intensity of fluorescence at certain time I (t) is measured against the average 
intensity over time < I (t) >. The intensity fluctuation is calculated as: 
 
δ 𝐼 𝑡 =  𝐼 𝑡 − <  𝐼 𝑡 >                                                    (1) 
 
with  
 
< 𝐼 𝑡 >= !
!
 𝐼 𝑡 𝑑𝑡!!                                                          (2) 
 
 Autocorrelation is used to describe the self-similarity of a time signal. The time 
dependent fluctuation can be quantified by the autocorrelation function (G(τ)) which is 
normalized as: 
 
𝐺(τ) = ! !! ! ∙ !! !!τ !
! ! ! !!
                                                         (3) 
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where 𝐼 𝑡 + τ  is fluorescence intensity at delay time τ. The signal self-similarity is 
analyzed in lag time τ. 
 
2.2.2 Single-component diffusion 
 Parameters of interest are determined after fitting the autocorrelation curve to the 
appropriate mathematical model. Here we start with the simplest situation that has one 
chemical species in the observation volume. In the most common model, the observation 
volume is assumed to be an ellipsoidal Gaussian resulting in the autocorrelation function 
derived as60-61 
 
𝐺(τ) = !
!"
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/!                                         (4) 
or 
𝐺(τ) = !
!
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/!                                          (5) 
  
where C is the average concentration, V is an effective observation volume and  τ! as the 
mean dwell time of the particle in the observation volume. 𝑉 = 𝜋!/!𝑟!!𝑧!  where 
𝑟!  𝑎𝑛𝑑 𝑧! are the lateral and axial dimensions of laser beam. N is the average number of 
particles in the defined observation volume and the local concentration can be determined 
from N. When in the limit 𝜏 → 0, 𝐺(0) is inversely proportional to the number of particle 
in sampling volume. As the number of particles increases, the relative fluctuation of a 
single molecule on total fluorescence decreases thus the amplitude of autocorrelation 
decreases. To maintain the sensitivity of measurement, it is important to minimize the 
concentration of sample between subnanomolar to submicromolar for the femtoliter sized 
illumination volume. 
 
 The dwell time  τ! is the characteristic time that a molecule resides in the illumination 
volume 
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 τ! =
!!!
!∙!
                                                                   (6) 
 
where D is the translational diffusion coefficient and 𝛼 is a constant, which equals 4 for 
one-photon excitation and 8 for two-photon excitation. 
 
2.2.3 Multi-component diffusion 
      When there are two species in the system but no interaction between them, the 
diffusion times for each of the species are independent. Considering the contribution of 
particles for each component, n1 and n2, to total fluorescence, the correlation function 
leads to60, 62 
 
𝐺 𝜏 =  
𝑛!!
𝑛! + 𝑛! !
∙ 𝐺! 𝜏 +  
𝑛!!
𝑛! + 𝑛! !
∙ 𝐺! 𝜏   
= !!
!!!
!!!!!!!!! !
1+ !
!!!
!!
1+ !
!!!!!
!!! + !!
!!!
!!!!!!!!! !
1+ !
!!!
!!
1+ !
!!!!!
!!!  
                               (7) 
 
where Q1 and Q2 are the quantum yields for individual component, and N1 and N2 are 
average numbers of particles of each component. 𝜏!! 𝑎𝑛𝑑 𝜏!!  are the independent 
diffusion times of two components crossing the illumination volume described by its 
structure parameter 𝜔 (𝜔 = 𝑟!!/𝑧!!). 
Similar to the equation above, it is not hard to derive the correlation function for the case 
of multiple non-interaction species as 
 
𝐺 𝜏 =
!!
!!!
∑!!!! !
1+ !
!!"
!!
1+ !
!!!!"
!!!
.                          (8) 
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2.2.4 Triplet state 
      To ensure the single-molecule level detection, a high turnover between the excited 
singlet state S1 to ground state S0 is required. There is a possibility that a part of excited 
molecules exist in the triplet state. According to the Jablonski diagram shown as figure 
2.1, the fluorescence emission occurs from the first excited level of electronic state S1 to 
the lowest vibrational level of the ground state S0. When the transition of energy 
undergoes an intersystem crossing process in which state the electron spin is parallel to 
the spin in its ground state, it is the so called triplet state (T).63  
 
 
Figure 2.1 Jablonski diagram.  
(Reprinted from http://www.tissuegroup.chem.vt.edu/chem-ed/quantum/jablonsk.html.) 
 
      The triplet state gives rise to phosphorescence, but also is able to revert back to the 
first excited singlet state S1 to emit fluorescence. The transition between excited singlet 
state and triplet state is radiationless and much slower than the relaxation time from S1 to 
S0 therefore causing a delay on emitting fluorescence.  Thus considering this triplet-
excited state, the expression of correlation function can be simplified as64 
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𝐺 𝜏 = !
!
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/! ∙ 1+
!"# (! !!!
)
!!!
                         (9) 
 
where T is the fraction of molecules in the triplet state and 𝜏! is the triplet relaxation time 
which can be determined by the forward and backward transition rate from the singlet to 
triplet state. For more than one fluorescent dye molecule having the triplet state, equation 
9 can be further modified to include a triplet correction term for each fluorescent species. 
 
2.2.5 Unimolecular isomerization and Cross-correlation 
      In more realistic situations, there exists interactions or chemical reactions between 
different species. Referring to the experiment did by Magde et al (1974), the reaction can 
be expressed like: 
 
                                                                 kAB 
A fluorescent    ⇌     B(non− fluorescent) 
                                                                 kBA       
 
      The fluorescence property of EtBr changes between binding and non-binding state. 
This unimolecular isomerization case is very similar to triplet state with two processes 
involved, diffusion and isomerization, but the diffusion rate will not influenced by 
isomerization process. Thus the correlation function leads to48 
 
𝐺 𝜏 = !
!
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/! ∙ 1+ 𝐾exp (− !
!!
)                    (10) 
 
where K is the equilibrium constant of reaction 𝐾 = !!"
!!"
 . 𝜏! is the relaxtion time of 
chemical reaction equal to (kAB+kBA)-1. 
 
      The interactions between two species can also be measured by labeling them with two 
different fluorescent dyes, like red and green, with independent excitation and detection 
but shared illumination volume. If two species move independently, the autocorrelation 
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can be analyzed for each individual species but no cross-correlation between two species 
will be observed. Only if two species couple and move as the same entity, will the cross-
correlation be measured. Assuming that the illumination volumes generated from red and 
green lasers are perfectly overlapped and the emission spectra are fully separable, the 
normalized cross-correlation function is defined for two fluorescent species, the 
independent green (G) and red (R) channels, as follows46, 65: 
 
𝐺! 𝜏 =
!!!!!"##! ! !!!!"!!"##! !
!!"(!!!!!!!!"!)!
                                    (11) 
 
 
𝐺! 𝜏 =
!!!!!"##! ! !!!!"!!"##! !
!!"(!!!!!!!!"!)!
                                    (12) 
 
And the cross-correlation function is derived as 
 
  𝐺!" 𝜏 =
!!!"!!"##! !
!!"(!!!!!!!!"!)(!!!!!!!!"!)
                               (13) 
 
where CG, CR and CGR are the concentrations of green-labeled, red-labeled and coupled 
components. VGR is the overlapped effective illumination volume. The amplitude of 
𝐺!" 𝜏  is inversely proportional to the concentration of complex. The motion-related 
term of the correction function is 
  
𝐷𝑖𝑓𝑓! 𝜏 =
!
(!! !!!,!
)(!! !
!!
!!!!,!
)
!
!
                                        (14) 
 
which describes the diffusion time of each component in the observation volume. 
Particularly, the diffusion time of coupled two-color fluorescent species (𝜏!,!")  is 
defined by the structure parameters from both the green (wG) and red (wR) beams under 
the two-photon excitation condition and expressed as 
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𝜏!,!" =
!!
!!!!
!
!!!"
.                                                     (15) 
 
2.3 Experimental Setup 
      The most common modern setup of FCS is shown as Figure 2.2.  The light source is 
one or more parallel setting commercial lasers with different wavelengths. The laser light 
passes through a beam expander and is reflected by dichroic mirrors into an objective 
with high numerical aperture. The fluorescent molecules in the confocal volume 
(observation volume) being excited originate fluorescence and then the emission signal is 
collected by the same object and transmitted through dichroic mirrors, an additional 
bandpass filter and a pinhole. Finally the fluorescence photons directly impinge on the 
detector that converts the emission signal into electronic pluses. The intensity fluctuation 
and autocorrelation curves will be calculated and displayed by the computer software. 
 
Figure 2.2 Schematic experimental setup for FCS measurements. (Reprinted from 
reference: Elke Haustein and Petra Schwille. Annu. Rev. Biophys. Struct. 2007. 36: page 
153.) 
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2.3.1 Laser source: One-photon excitation and two-photo excitation 
      In the last couple of decades, laser diodes have been commonly used as a light source 
in standard spectrofluorometers. In FCS, the main requirement for the light source is high 
intensity stability because the intensity fluctuation introduced by the laser cannot be 
separated from the fluorescence fluctuation from sample emission. In addition, a highly 
focused illumination volume is needed to limit the number of particles excited at any one 
time.   
 
      Generally, fluorophores absorb the energy from one photon to reach the excitation 
state shown as one-photon excitation in Figure 2.3 on the left side. In the 1990s, Denk, 
Strickler and Webb applied the multi-photon method (a concept first described by Maria 
Goeppert-Mayer in 1931) and developed two-photon excitation fluorescent microscopy.66 
Basically, two photons with each carrying approximately half the energy of one-photon 
excitation can be absorbed simultaneously and excite the fluorophore in a single quantum 
event. 
 
 
Figure 2.3 Jablonski diagrams for one-photon excitation and two-photon excitation. 
(Reprinted from Biomedical Optics Lab in Middlebury College 
http://sites.middlebury.edu/durst/research/.) 
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 For one-photon excitation FCS, low laser power (<1 mW) is sufficient for 
measurement. Argon ion (λ = 488 nm) and HeNe (λ = 633 nm) laser diodes are the most 
commonly used laser sources for green and red fluorophore measurement.  Two-photon 
excitation FCS requires a near-infrared laser with high instantaneous photon flux 
densities (~1032 photons/cm2) that sufficient for two-photon absorption. Most two-photon 
systems use the titanium-sapphire laser which covers a wide range of wavelength from 
690 to 1050 nm and provides high average power (about 1 KW), high repetition 
frequency (80 MHz), and short pulse width (~100 fs).67  
 
 The two-photon excitation applied in conventional FCS offers several advantages 
including (i) the scattered light from background can be greatly minimized because of the 
wide separation between excitation and emission wavelength and (ii) the out-of-focus 
photobleaching can be reduced because the laser with infrared wavelength is usually not 
absorbed by sample.68 With deeper penetration and reduced photodamage, two-photon 
FCS is ideally suited for a study of biological samples like living cells or tissues.  
 
2.3.2 Confocal microscopy 
 As discussed above, a clear requirement of FCS is a small, well-defined illumination 
volume to reduce the number of fluorophores in observation at a given time point. 
Therefore, high fluorescent intensity with high signal to noise ratio is required. To 
achieve this, the confocal illumination scheme is applied to FCS and that brings great 
improvement on the spatial resolution by reducing the background fluorescence. 
 
 Figure 2.4 shows the principle of a confocal microscope. The excitation laser beam 
gets reflected on a dichroic mirror and focused into the sample by a high Numerical 
Aperture (NA) microscope objective. In an ideal case, fluorescence arises from a unique 
focal plane and is collected by detectors. However, when the sample is thicker than the 
focal plane, there will be out-of-plane fluorescence emission generated in the whole 
illumination volume. This scattered excitation light from different depths within the 
sample can also reach the detectors giving rise to background noise. To reduce this noise, 
confocal microscopy takes advantage that the lights from different depths are spatially 
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separable. By placing a pinhole at the proper position conjugated to the illumination focal 
plane, the light originating from out-of-focus regions can be blocked. The scattered light 
reaching the detector is thus greatly attenuated.68 
 
 
 
Figure 2.4 Illustration of the operational principle of a confocal microscope. 
 
2.3.3 Detectors: PMT and ADP 
 In a modern FCS setup, the most commonly used detectors are a photomultiplier tube 
(PMT) and avalanche photodiode (ADP). Shown in Figure 2.5, PMTs produce an output 
signal following the processes: an incoming photon liberates an electron from the 
photocathode, the photoelectrons are than accelerated in an electric field and pass through 
a focusing electrode to hit on the dynodes. Dynodes are electrodes with each one held at a 
more positive potential, by about 100 Volts, than the previous one. Therefore the 
photoelectrons generated from preceding dynodes will be attracted to the next one and 
generate more electrons. Afterwards a chain reaction starts from the first dynode to the 
last so that a cascade of electrons is finally collected and converted into voltage. In this 
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manner, the signal from an individual photon can be greatly multiplied thus the device is 
described as a photomuliplier.69 
 
 
Figure 2.5 Schematic diagram of Photomultiplier tubes. (Reprinted from Australian 
Microscopy & Microanalysis Research Facility 
http://www.ammrf.org.au/myscope/confocal/confocal/lasers.php.) 
 
 ADP is essentially the equivalent of the PMT but electron amplification occurs in a 
semiconductor based internal structure. As shown in Figure 2.6, the incident photons first 
generate electron-hole pairs in the silicon photodiode layer. With applied strong electric 
field, these electron-hole pairs move towards the respective PN junctions with high speed 
(up to 105 m/s) and thus increase the electric field between electrodes. This gain in 
electric field strength ionizes more electron-hole pairs to cause further gains in ionization. 
So this avalanche process significantly amplifies the input photon signal. Compared to 
PMTs, advantages of ADPs include smaller size, higher speed, lower capacitance and 
better linearity. ADPs have higher signal-to-noise ratio in the longer wavelength regions 
of the spectrum (> 500 nm) but lower sensitivity in the blue wavelength region (~400 
nm).68 
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Figure 2.6 Schematic diagram of an Avalanche photodiode. (Reprinted from 
http://www.photonics.com/EDU/Handbook.aspx?AID=25535.) 
 
2.4 Biological and chemical applications of FCS 
 
2.4.1 Translational diffusion and size studies 
 The most direct measurement performed with FCS is the measurement of translation 
diffusion. The major advantages in using FCS rather than other techniques are, first the 
observation volume is very small which gives direct local measurement with minimized 
disruption from biomolecular environment. And more importantly, the measurement is 
non-invasive which reduces the phototoxicity for biological samples like a living cell. To 
study the diffusivity, molecules of interest must be labeled with a fluorescent dye, and 
their diffusion-based motion results in the autocorrelation curve with the characteristic 
diffusion times and their diffusion coefficients are then determined. 
 Molecular size is another interesting parameter that can be predicted by diffusivity 
study. According to the Stokes-Einstein equation, the hydrodynamic radius Rh of a 
spherical particle can be estimated: 
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𝑅! =
!"
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                                                           (16) 
 
where D is the translational diffusion coefficient, k is the Boltzman constant, T is the 
temperature, η is the viscosity of medium. In this way, the size of particles in solutions 
can be better characterized compared with other techniques like electron microscopy 
since the particles have an additional hydration shell in solution. Also the apparent size in 
different aqueous or organic solvents can also be characterized by knowing the viscosity. 
 
2.4.2 Local concentration 
 As the amplitude of the autocorrelation curve is inversely proportional to the average 
number of particles in the observation volume, the concentration and change of 
concentration of fluorescently labeled molecules can easily be determined. With the high 
spatial resolution resulting from small sampling volume, FCS can be used to investigate 
the local concentration in an adsorption process or a ligand-receptor binding process. As 
the local concentration is much higher than the highly diluted bulk concentration under 
this circumstance, a direct measurement is therefore crucial to determine exact binding 
coefficients.47  
 
2.4.3 Molecular interactions 
 Interactions between biomolecules, like protein-protein and receptor-ligand binding, 
are also well-suited for FCS studies. Typically a small fluorescently labeled compound 
binds onto a larger object resulting in a complex with a significantly slower translational 
diffusion coefficient.  When the chemical kinetics of binding/debinding processes is 
much slower than the diffusion kinetics of the molecules across the observation volume, 
the two-component autocorrelation function is used to resolve the two contributions: the 
fast diffusion of free small molecules and slow diffusion of bound complexes. 
Furthermore, by analyzing the correlation function using a two-component model, the 
fractions of both bound and unbound molecules can be determined and thus the binding 
stoichiometry is determined. Figure 2.7 is a schematic showing how  FCS autocorrelation 
curves change from a pure single component to a pure complex of greater size.70 
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Figure 2.7 Theoretical FCS autocorrelation curves expected for study a series of binding 
processes by using FCS. In the intermediate binding states, two diffusion components are 
detectable (red, green and blue curves). (Reprinted from Ly, S., et al., Quantifying 
Interactions of a Membrane Protein Embedded in a Lipid Nanodisc using Fluorescence 
Correlation Spectroscopy. Biophysical Journal, 2014. 106(2): p. L5-L8.) 
 
 In some situations, like enzyme binding with substrate, the size difference between 
free species and bound complex is small. This makes the change in diffusion times hard 
to distinguish by FCS since the dynamics of diffusion is typically on a logarithmic time 
scale. In this case, dual-color Fluorescence Cross Correlation Spectroscopy (FCCS) was 
developed to solve this drawback. The principle of FCCS is mentioned in chapter 2.2.5.  
In FCCS, two components are separately labeled with distinct dyes with minimal overlap 
in fluorescence emission. Two emission signals are acquired simultaneously while 
separately by two channels. A cross-correlation of the two channels will only be observed 
for complexes containing both molecules.  If there is no interaction between two labeled 
species, the channel 1 and 2 will present the diffusion of each individual component, 
respectively, showing no cross-correlation signal (Figure 2.8 A). If interaction occurs 
between the two-labeled species, a cross-correlation signal is observed (Figure 2.8B). The 
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amplitude of the cross-correlation function directly corresponds to the concentration of 
the complexes carrying both fluorophores. Thus, FCCS allows for the determination of 
the number and kinetics of molecular interactions, like association or dissociation 
processes, despite the indistinct size difference.46 
 
Figure 2.8 Schematic of using FCCS to determine the interaction between green and red 
labeled species. (A) represents that there is no interaction between two labeled species 
with showing no cross-correlation. (B) represents that interaction occurs between the 
two-labeled species and a cross-correlation signal is observed. (Reprinted from Stowers 
Microscopy Center 
http://research.stowers.org/microscopy/external/Technology/FCS/index.htm) 
 
2.4.4 More in vivo applications with advanced FCS (TIR-FCS AND RICS) 
 In recent years, FCS has been combined with alternative detection schemes to extend 
its application to measurement of the dynamics in a heterogeneous system and living 
biological systems. As many essential processes occur on cell membranes, like immune 
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response, ion transfer or receptor-ligand interactions, it is important to learn the dynamics 
on the cellular membrane. FCS has the potential to be utilized in the study of diffusion 
behavior of membrane-bound molecules and also the binding and unbinding process to 
and from the membrane.71-72 However, the thickness of the lipid bilayer is generally less 
than 10 nm, which is several orders of magnitude smaller than the axial length of the 
typical FCS observation volume. As a result, the measurement of membrane-bound 
molecules will be compromised by the freely diffusing molecules above and below the 
membrane of interest.72 This problem can be addressed by applying the Total Internal 
Reflection principle to FCS (TIR-FCS). In TIR-FCS, the laser approaches to the interface 
between media (from high refractive index to low refractive index) with an appropriate 
angle to make the light totally reflected. The total internal reflection allows some energy 
to penetrate through the interface to form a ~100 nm thin layer excitation region, giving 
rise to an evanescent field. The evanescent beam is only able to excite the fluorescent 
molecules close to the surface of interface therefore the detection volume is narrowed 
down to attoliters (~10-18L) and axial resolution is greatly enhanced.59, 73 The depth of the 
evanescent field can be tuned by the angle of the incoming beam.  This refinement makes 
TIR-FCS ideal to investigate the diffusion of molecules in the membrane, the interactions 
with the membrane and the kinetics of other cellular processes. 
 For some slow-moving biological samples, like protein clusters, with limited complex 
diffusion the incorporation of laser scanning techniques has allowed for the measurement 
of aggregation kinetics within samples. Raster Image Correlation Spectroscopy (RICS) 
can repetitively move the focal point to obtain images of different sections within a 
sample. The fluorescent intensity at one pixel is correlated in time with the intensity at 
the same pixel in following frames. In this matter, spatial-temporal information of the 
labeled species is able to be extracted from the images.74-75 Nowadays, RICS has been 
commonly applied to separate the immobile from mobile fraction, distinguish the 
diffusion from binding and study the diffusion in complex biological environments such 
as cell interiors. 
 
Copyright © Xiaolu Zhang 2015 
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Chapter 3 Probe molecule transport in hydrogels 
 
3.1 Introduction  
To reach specific loci in target cells, molecules of interest must traverse complex 
surroundings consisting of a crowded, interacting environment of biomacromolecules. 
Molecule diffusion through biological gels such as the cytoplasm, mucus, nuclear pore 
complex, or the extracellular matrix (ECM) is dictated by the local environment and 
critical for proper functioning of cell processes.41-42, 76-78 Due to their importance as 
protective barriers against viruses, bacteria, and toxic agents, there has been substantial 
research in recent years to obtain a better understanding of the transport processes 
governing the diffusion and penetration of particles through biogels. Although free 
diffusion of molecules is well understood physically, how the biomacromolecules in 
these crowded environments affect the mobility and transport of nanometer-sized 
particles is a key aspect of biology that is not yet fully understood.  
3.1.1 Biological hydrogels have complicated filtering strategies 
Biological hydrogels are networks that surround biological entities like cells, tissues, 
organs or entire organisms. They consist of protein-polysaccharide chains and typically 
contain 90%-99% water. In addition to their mechanical properties, these biogels can also 
act as selective barriers that control the exchange of molecules between different 
compartments.44 Despite this important barrier function, little is currently known about 
the structure, dynamics and molecular interactions that allow these biogels to selectively 
filter particles.  
The diffusion of nanoparticles in polymer gels has been studied extensively both 
experimentally and theoretically. Typically for biological applications, the range of 
interest is when the particle size is on the order of the gel correlation length or mesh size, 
ξ. From steric arguments alone, one would anticipate that as nanoparticle size approaches 
ξ, the transport of the molecule through the gel will be inhibited, resulting in size filtering; 
i.e., large particles move more slowly.79 However, recent studies have shown that 
movement of particles in biogels, including the extracellular matrix and nuclear pore 
complex, can depend on the charge and size of the particles as well as the properties of 
the network.41-42, 44-45, 80-81 There is growing evidence that more complex interactions 
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between the diffusing particle and the polymer matrix result in a more intricate selection 
process called interaction filtering, which allows some particles to pass through the 
network and others to be kept out.43-45, 80, 82-83 For instance, a recent study found that 100 
nm coated polystyrene beads were much more strongly immobilized inside undiluted 
human mucus than were 200 and 500 nm polystyrene beads with the same coating.84 This 
directly contradicts the idea that the finite mesh size of cross-linked hydrogels is solely 
responsible for hindered diffusion in bionetworks.  
3.1.2 FCS to measure dynamic processes inside hydrogels 
Particle-gel interactions in vivo may include many specific and nonspecific 
interactions, such as electrostatics, hydrophobic interactions, and chemical binding.82, 84-85 
To gain insight into these complex interactions, it is instructive to examine transport 
properties within simpler model systems such as water-soluble polymer networks. 
Although most experimental methods do not allow for the direct measurement of 
diffusion coefficients in turbid media, it has been shown that fluorescence correlation 
spectroscopy (FCS) effectively measures the dynamic processes of small molecules in 
polymeric systems, hydrogels, and tissues.79, 86-93 In FCS, the diffusion coefficient, D, of 
fluorescent particles is calculated from the autocorrelation of the recorded intensity 
fluctuations through a defined illumination volume. Some of the advantages of FCS over 
alternative methods are that only a small illumination volume (~fL) and low 
concentrations of fluorescence particles, typically nanomolar, are required minimizing 
particle-particle interactions. In this chapter, we will discuss FCS experiments performed 
to determine the translational diffusion coefficients (D) of a charged probe molecule 
(Alexa488, -2 charge at near neutral pH) in uncharged and charged polymer solutions. 
Both positive and negative polymer networks are used to compare the effects of attractive 
and repulsive charge interactions.  We find that particle transport through hydrogels is 
highly charge asymmetric. Repulsive charge interactions are not effective, whereas 
attractive probe-gel interactions are very effective in significantly hindering particle 
diffusion through the gel. Addition of salt increases particle diffusivity and for large salt 
concentrations renders the diffusivity the same as in a corresponding neutral polymer 
network, demonstrating the importance of electrostatic interactions, in agreement with 
biological findings in mucus77 and the nuclear pore complex41-42. The salt concentration 
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range where these interactions are screened occurs at a characteristic crossover salt 
concentration, indicating the potential of salt to function as a gating switch in these 
hydrogel systems. 
 
3.1.3 Modeling and Brownian dynamic simulations 
Although free diffusion of particles and the effect of steric and hydrodynamic 
interactions between particle and gel are reasonably predicted theoretically, electrostatic 
effects on diffusion of charged particles in charged gels are still poorly understood. There 
have been a number of different attempts at devising a useful simulation model consisting 
of a cubic and periodic environment suitable for Brownian dynamics (BD) simulations.43, 
94-98 Early work focused on steric effects94, 97-98, whereas more recent studies have begun 
to include some form of electrostatic interaction43, 95-96. The aim of such models is to 
approximate the specific interaction inside a real hydrogel in a manner that can be readily 
implemented in simulations and is of reasonable computational cost. The need for such 
models is driven by experimental results that suggest that particle-matrix interactions 
other than steric effects are most influential on the diffusivity of particles inside 
biological hydrogels. These interactions seem to be of an electrostatic nature, since the 
mobility is highly dependent on the particle surface charge42, 44, 80, 84-85, 99-100 and the salt 
concentration44-45, 80, 101-102. 
To better the understanding of nanoparticle diffusion in charged biomacromolecular 
gels, we collaborated with Dr. Roland Netz’s group (Department of Physics, Free 
University of Berlin) to propose a simple theoretical model that approximates a real 
polymer network as a cubic and periodic lattice of connected polymer chains. This cubic 
lattice is comprised of rigid, straight chains that interact either attractively or repulsively 
with the diffusing particle. BD simulations were implemented for spherical tracer 
particles to understand the key factors influencing the diffusivity of the particles inside 
the polymer network. BD simulations were performed by the Netz lab and will only be 
discussed briefly here for quantitative comparison to the FCS experiments performed at 
UK.  Using BD simulations, we examined the dependence of particle diffusion on short-
range screened electrostatic interactions, mesh size, and particle size within the hydrogels. 
Simulation outcomes are in quantitative agreement with our experimental results of 
	 31	
diffusion of charged probe molecules within charged networks. To our knowledge, this is 
the first work showing quantitative comparison between measurements and theory of 
these asymmetric charge effects. Both theory and experiments show that probe transport 
within charged hydrogels is governed by both the sign of the interaction potential and the 
ionic strength. The significant decrease in diffusion for attractive charge interactions is 
revealed by BD simulations to be due to the charged particles sticking at the vertices of 
the oppositely charged matrix polymer network. 
3.2 Materials and methods  
3.2.1 Materials  
 Polyethylene glycol (PEG) (20 kDa), dextran (15-25 kDa) dextran (500 kDa), 
carboxymethyl-dextran (CM-dextran(-), 15-20 kDa), and diethylaminoethyl-dextran 
(DEAE-dextran(+), 500 kDa) were purchased from Sigma Aldrich (St. Louis, MO). CM-
dextran is negatively charged, whereas DEAE dextran is positively charged and pure 
dextran is charge-neutral. A variety of water-soluble fluorescent probe molecules were 
purchased for FCS measurements. Rhodamine 110 (R110) (absorbance/emission 
(Abs/Em) maxima, 496/520 nm) was purchased from Fisher Scientific (Waltham, MA). 
Rhodamine 6G (R6G) (Abs/Em maxima, 530/556 nm) was purchased from Sigma 
Aldrich. Alexa Fluor 488 succinimidyl ester dye (Alexa488) (Abs/Em maxima, 495/519 
nm) and the fluorescent protein R-phycoerytherin (Abs/Em maxima, 546/578 nm) were 
purchased from Invitrogen (Carlsbad, CA). All of the fluorescent probe molecules were 
used without further purification.  
3.2.2 Preparation of PEG and dextran solutions  
 PEG and dextran (neutral dextran, CM-dextran(-), and DEAE-dextran(+)) stock 
solutions of 10% w/v were prepared by weighing out the appropriate amount of polymer 
powder as received, dissolving in milli-Q water (Millipore, Billerica, MA), and mixing 
thoroughly. These solutions were subsequently dialyzed overnight against a large excess 
of milli-Q water to remove additional salts. After dialysis, solutions were lyophilized 
back to dry powder. The dialyzed polymers were subsequently dissolved at 10% w/v in 
MES buffer (10 mM, pH=6.4), stirred thoroughly, and incubated at room temperature 
overnight. Subsequent dilutions with MES were made from the stock solutions, resulting 
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in final concentrations of 1–8% w/v polymer solutions. All polymer solutions were 
allowed to incubate for 1 day before use.  
 For FCS experiments, fluorescent probe molecules were prepared and mixed with 
polymer (PEG or dextran) solutions to achieve a final probe concentration of ~5–10 nM. 
Samples of probe molecules in polymer solutions were mixed thoroughly then incubated 
at room temperature for > 6 h to ensure uniform dispersion of the probe molecules 
through the sample. From each solution, 500 µL of sample was loaded into NUNC 
LabTek 8-well microscopy chambers (Nalge Nunc, Penfield, NY) and measured directly 
by FCS at room temperature.  
 
3.2.3 FCS setup and data analysis 
 FCS experiments were made using a commercial ISS Alba confocal fluorescence 
fluctuation system coupled to a Nikon Ti-U microscope equipped with a 60/1.2 NA 
water-immersion objective lens. The illumination source was a continuous-wave 488 nm 
laser diode passed through a 514 nm longpass edge filter before detection. Emission 
signal was recorded by two separate photomultiplier tube (PMTs). All FCS 
measurements were performed in NUNC LabTek 8-well microscopy chambers (Nalge 
Nunc) with a final volume of ~500 µL. Determination of the focal volume was 
established via calibration against an aqueous solution of rhodamine 110 with known 
diffusion coefficient (D= 440 µm
2
s
-1
).103 FCS results are an average of at least 20 
measurements, taken at various positions within the polymer solutions to ensure 
homogeneity, with typical sampling times of 30 s. All results are expressed as the mean ± 
SD of the measured diffusion coefficient. FCS measurements were analyzed using 
VistaVision 4.0 software (VWR, Radnor, PA).  
 As the basic principles of FCS have been described in detail in chapter 2, we give 
only a brief overview here. FCS measures the fluorescence fluctuations emitted from 
labeled molecules moving in and out of a small confocal volume (~1 fL). The size of the 
effective illumination volume is fixed by the confocal detection optics and the excitation 
profile of the focused laser beam and characterized by measurements against a standard 
of a known diffusion constant. For ideal particles of uniform size diffusing by Brownian 
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motion, dynamic information can be determined from the intensity fluctuations by means 
of a time autocorrelation given by  
𝐺(τ) = !
!
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/!.                                           (1) 
Here, N is the average number of particles in the illumination volume and the structure 
parameters r0 and z0 are the axial and radial dimensions of the excitation beam 
determined by calibration measurements against a known standard. The autocorrelation 
can then be normalized by 
𝐺!"#$ 𝜏 =
!(!)
!(!)
.                                                          (2) 
 The diffusion time, τD, is related to the translational diffusion coefficient D by the 
simple relationship 
 τ! =
!!!
!∙!
,                                                                (3) 
where D denotes the translational diffusion coefficient of the molecules in solution and is 
calculated from the lateral dimensions of the focused incident beam and the 
experimentally determined τD. For spherical particles, the diffusion coefficient D follows 
from the hydrodynamic radius, rh, in solution and can be calculated by the Stokes-
Einstein relation D=kBT/6πηrh, where kB is the Boltzman constant, T is the temperature, 
and η is the viscosity of the medium. 
3.2.4 BD simulation 
 Brownian dynamic (BD) simulations were performed in the laboratory of Professor 
Roland Netz (Free University Berlin).  In a BD simulation the random walk of a diffusing 
particle follows from the Langevin equation 
𝑟! 𝑡 =  −𝜇!∇!𝑈 𝑟 𝑡 + 𝜁! 𝑡 ,   𝑖 = 𝑥,𝑦, 𝑧                           (1) 
where 𝑟!, ∇! and 𝜁! are the time derivative of the particle position, the spatial derivative, 
and a random velocity in 𝑖-direction, respectively. 𝑈 is the potential, 𝑡 the time and 𝜇! the 
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bulk sphere mobility. The random velocity 𝜁!  is a stochastic variable, modeled with 
Gaussian white noise to simulate the random collisions of the particle with solvent 
molecules:   
𝜁! 𝑡 = 0,                                                                 (2) 
𝜁! 𝑡 𝜁! 𝑡 = 2𝜇!𝑘!𝑇𝛿 𝑡 − 𝑡′ 𝛿!"  .                                      (3) 
 In a BD simulation, the Langevin equation is evaluated stepwise to create the 
diffusive motion of the particle inside the model system. At every time step, the mobility 
forces acting on the particle are calculated and a Gaussian distributed random 
displacement is added. 
 A simple cubic lattice comprised of polymer chains is used to model a cross-linked 
hydrogel. Figure 3.1 shows a unit cell of this the lattice, including particle distributions 
for a) attractive and b) repulsive electrostatic interactions.  Here, the “rods” of the lattice 
represent the polymer chains and the size of a single cell 𝑏 for “box size” corresponds to 
the average mesh size of the hydrogel.  The symmetry of the system allows for the usage 
of periodic boundary conditions. The diffusing particle experiences a total potential 
𝑈 = 𝑈!! + 𝑈!!!!!!                                                    (4) 
where the subscripts 𝑒 and 𝑠 denote electrostatic and steric interaction, respectively. The 
index 𝑖 denotes the contributions to the total potential by the individual rods. For 
computational efficiency the summation is limited to a suitably chosen finite number of 
𝑀 nearest neighbor rods.  
 The steric effect is included in the form of a truncated Lennard-Jones (LJ) potential 
similar to the one used by Zhou and Chen:104  
𝑈! 𝑅 =   4𝜖 !
!!
!"
− !
!!
!
+ !
!
, 𝑅 ≤ 𝑅!                            (5) 
𝑈! 𝑅 = 0, 𝑅 > 𝑅!                                       (6) 
where the energy depth is 𝜖 = 1 𝑘!𝑇 (≈ 4.1 ⋅ 10-21J at 25°C), 𝑝 the particle diameter and 𝑅 
the distance between the particle center and the rod. The potential is truncated at the 
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cutoff distance 𝑅! = 2!! ! 𝑝, which corresponds to the value of 𝑅 at which the LJ 
potential has its minimum. 
To include the electrostatic interaction between a diffusing particle and a polymer 
chain, an exponential interaction potential is used: 
𝑈! 𝑅 = 𝑈!𝑒𝑥𝑝
!!
!
                                               (7) 
where R is the radial distance between the particle and the rod, 𝑘 the range of the 
potential and 𝑈! is the potential strength. The potential only acts between particle and 
rod, since the individual rods are static and do not interact with each other. For negative 
𝑈! the potential is attractive and for positive 𝑈!  it is repulsive. A simple exponential 
potential has been chosen in a generic form to represent a short-range interaction, where 
the range 𝑘 can be understood as the Debye screening length of the potential, given by 
𝑘! = !!!!!!
!!!!
                                                         (8) 
where 𝑒 is the elementary charge and 𝐼 = !
!
𝑛!! 𝑧!! the ionic strength, 𝑧 the valence of the 
salt ions and 𝑛 their bulk number densities. The strength of the potential 𝑈!, scaled with 
𝑘!𝑇, can be interpreted as the product of the particle charge and polymer charge density. 
It is important to note the relative units of the variables. All spatial variables will be given 
in units of 𝑏, i.e. relative to the box size. Hydrodynamic effects are disregarded. 
Furthermore, the model is designed as a strong simplification of the realistic scenario of 
particle diffusion in hydrogels, with a focus on electrostatic interaction between hydrogel 
and particle.  
 In the long-time limit, the mean square displacement (MSD) of the particle becomes 
proportional to the diffusion parameter 
lim!→! r 𝑡 − r 0
! = 6𝐷𝑡                                 (9) 
 The diffusivity 𝐷 of the particle is obtained by linearly fitting the MSD in the long-
time limit, where it approaches a constant value. The diffusion parameter for particle 
diffusion without any interactions is 𝐷!, i.e. the free diffusion coefficient in water, which 
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follows from the Einstein equation 𝐷! = 𝜇!𝑘!𝑇. Most of the simulation results are 
focused on the relative diffusivity 𝐷/𝐷! to show how much the particle diffusion is 
inhibited inside the hydrogel. Values of the relative diffusivity lie in the interval 0 ≤ 
𝐷/𝐷! ≤  1, where 𝐷/𝐷! = 0 corresponds to complete immobilization of the particle and 
𝐷/𝐷! = 1 to free diffusion. 
 
Figure 3.1 Simulation unit cells including 2000 particle-position snap-shot obtained 
during one simulation run at an attractive interaction potential with strength U0=-5kBT 
(left) and a repulsive interaction potential with strength U0=5kBT (right). In both cases, 
the interaction range is set to k=0.3b and the effective particle diameter is p=0.1b. The 
length b denotes the box size. (This figure is adapted from: Biophysical Journal Volume 
108 February 2015 530–539 with the permission from Biophysical Journal.) 
 
 
3. 3 Results and Discussion 
	
3.3.1 Probe diffusion in uncharged polymer solutions  
  To disentangle steric and electrostatic effects, we first investigated the diffusion of a 
variety of small fluorescent probe molecules and the larger fluorescent protein R-
phycoerythrin in uncharged PEG solutions to determine steric contribution. Figure 3.2 
shows the scaled translational diffusion coefficients (D/D0) as determined by FCS for 
three similar-sized probe molecules (Rh110, Rh6G, and Alexa488) and R-phycoerythrin 
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as a function of PEG polymer concentration (0–8% w/v). D0 is the translation diffusion 
coefficient of each molecule in buffered water without polymer as determined by FCS. 
FCS autocorrelation curves show an increase in the characteristic diffusion times of these 
probe molecules with increasing PEG concentration. All autocorrelation curves are well 
described by a single-component fit, allowing for the extraction of N and τD from 
Equation 1. Translation diffusion coefficients (D) can be calculated from the 
autocorrelation curves using Equation 3. Using the Stokes-Einstein relationship, we 
obtain hydrodynamic radii of rh ~ 0.6 nm for each of the fluorescent dyes and rh ~ 5.6 nm 
for the phycoerythrin protein in water, consistent with published data.93 FCS is also very 
sensitive to aggregation. No signs of large aggregates or decrease in the number of 
molecules are observed, suggesting that probes freely diffuse within the polymer 
networks. Similar results are observed in uncharged dextran solutions, indicating that 
these probe molecules do not interact (e.g., immobilization, aggregation, or 
photobleaching) significantly with the sugar backbones of the dextran network.  
Several different physical models based on hydrodynamic interactions have been used in 
recent years to model probe diffusion in uncharged networks. These theories posit that 
hydrodynamic and steric interactions are the dominant force determining particle 
transport in the gels. Despite developing from different physical mechanisms, most 
models derive equations to describe probe diffusion that can be expressed in the form of a 
stretched exponential.105-111 The solid lines in Figure 3.2 depict best fits to the data using 
D=D0exp(-αc
n), where D0 is the probe diffusion coefficient in pure solvent, c is the 
polymer concentration, and α and n are constants dependent on the probe-gel system. 
Typically, n reflects the polymer solvent quality and α is dependent on other relevant 
system parameters (such as probe radius, molecular mass, etc.) contingent on the specific 
model. Measured α and n values are listed in Table 3.1 and are in good agreement with 
previously published data of probe molecule diffusion in poly(vinyl alcohol) solutions.93 
All n values are in the range 0.68–0.88, where n = 0.75 has been suggested to correspond 
to water being a good solvent for the polymer.109 Values of a range from ~0.2 for the 
rhodamine and Alexa probe molecules to ~0.5 for the larger phycoerythrin in PEG. 
Similar values of α and n are obtained in uncharged dextran solutions.  
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Figure 3.2 Scaled diffusion coefficients of various probe molecules as a function of PEG 
concentration. Solid lines are fits of the data with the stretched exponential D=D0exp(-
αcn), where α and n are fitting parameters. Values of the parameters (see Table 3-1) are 
consistent with previously measured values in poly(vinyl alcohol). (This figure is adapted 
from: Biophysical Journal Volume 108 February 2015 530–539 with the permission from 
Biophysical Journal.) 
 
Table 3.1 Exponent and prefactor values determinded from best fits of D=D0exp(-αcn) to 
data. 
Probe α n 
R110 0.20 0.80 
R6G 0.17 0.83 
Alexa488 0.26 0.65 
R-Phycoerythrin 0.48 0.88 
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3.3.2 Probe diffusion in charged polymer solutions  
To examine the role of electrostatic interactions on nanoparticle transport in polymer 
networks, we next used FCS to determine probe translational diffusion coefficients within 
charged dextran solutions. Here, we focus on one probe molecule, Alexa488, which has a 
net charge of -2 at neutral pH. We looked at diffusion of Alexa488 in CM-dextran(-) 
(molecular mass ~20 kDa) and DEAE-dextran(+) (molecular mass ~500 kDa). We use 
the notation dextran(-) and dextran(+) from here on to more easily distinguish the 
network charge in these systems. Dextran(-) has approximately one negative charge per 
five glucoses, whereas dextran(+) has approximately one amine group per three glucoses. 
These two dextrans had very different molecular mass, so for comparison, we also 
examined the probe diffusion in both 20 kDa and 500 kDa uncharged dextran solutions 
(dextran20 and dextran500, respectively). To ensure that Alexa488 was uniformly 
distributed throughout the dextran solution, FCS measurements were performed at 
various spots within the solution and averaged.  
Normalized autocorrelation functions of the negatively charged Alexa488 in solutions 
of dextran(-) and dextran (+) as a function of polymer concentration are shown in figure 
3.3, A and B, respectively. Figure 3.3 A reveals that in gels with the same charge as the 
probe molecule, the characteristic diffusion time, τD, of Alexa488 increases only weakly 
with increasing dextran(-) concentration. Translation diffusion coefficients, D, as 
determined from Equation 3, are plotted in Figure 3.4 for dextran (-) from 0 to 8 wt % 
dextran. As can be seen, the measured diffusion coefficients in dextran(-) are nearly the 
same as D observed in uncharged dextran of comparable molecular mass (dextran20). In 
comparison, Figure 3.3 B shows the normalized correlation functions measured by FCS 
for the negatively charged Alexa488 probe in dextran(+). Here, we see large shifts in the 
characteristic diffusion time, τD, that are highly dependent on the dextran(+) weight 
percentage. The largest shift in the characteristic diffusion time, or, equivalently, the 
largest decrease in the translation diffusion coefficient, D, is observed between the no-
polymer-network state (or 0 wt % dextran) and 1 wt % dextran(+). Increasing the 
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dextran(+) concentration further resulted in an observed decrease in τ or, equivalently, an 
increase in the apparent D. This decrease in τ is likely due to a higher counterion 
concentration adding to the ionic strength of the solution in the higher-weight-fraction 
dextran(+) networks. Figure 3.4 shows the measured translational diffusion coefficients 
for both dextran(+) and the comparable neutral-molecular-mass dextran (dextran500).  
We anticipated that our negative Alexa probe would be slowed in neutral dextrans 
with increasing weight percent due primarily to steric interactions. With the introduction 
of electrostatics, we expected repulsive interactions (i.e., negative probe in negative gel) 
to slow the probe down due to the probe particles avoiding the gel polymers, whereas 
attractive interactions (negative probe in positively charged gel) would hinder the probe 
transport the most because the probe would stick to the gel. Instead, as shown in Figure 
3.4, Alexa488 diffusion in dextran20 is nearly identical to that in dextran(-), both ~20 
kDa mol wt polymers, and diffusion in both is comparable to that in dextran500. 
However, attractive interactions severely reduce probe transport. Comparing dextran500 
and dextran(+), we see significant decreases in the Alexa488 transport through the 
oppositely charged dextran polymer network due to electrostatics alone. 
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Figure 3.3 (A) Representative plots of normalized FCS autocorrelation curves of 
Alexa488 NHS ester (net charge -2) in 10 mM MES buffer, pH 6.4, and 1, 3, and 5 wt % 
dextran(-) solutions. (B) Normalized FCS autocorrelation curves for Alexa488 NHS ester 
in 10mM MES buffer, pH 6.4, and 1, 3, and 5 wt % dextran(+) solutions. In both A and B, 
solid lines represent fits to the experimental data by Eq. 1. (This figure is adapted from: 
Biophysical Journal Volume 108 February 2015 530–539 with the permission from 
Biophysical Journal.) 
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Figure 3.4 FCS measured diffusion coefficients of Alexa488 as a function of charged and 
uncharged dextran concentrations. Negatively charged CM-dextran and positively 
charged DEAE-dextran solutions were compared directly to neutral dextrans of 
comparable molecular mass (20 kDa and 500 kDa, respectively). Significant changes 
were observed only for the negatively charged probe in positively charged dextran 
solutions. (This figure is adapted from: Biophysical Journal Volume 108 February 2015 
530–539 with the permission from Biophysical Journal.) 
 
 
3.3.3 Salt effects on probe-network interactions  
 Next, we investigated the effect of added NaCl salt concentration on the electrostatic 
interactions between the probe and the network. Any electrostatic effects would be 
expected to have a strong salt dependence due to the Debye screening of the electrostatic 
interactions. Plotted in Figure 3.5 are the diffusion coefficients, D, for Alexa488 probe 
molecules in 1 wt % charged and uncharged dextran solutions as a function of added 
NaCl salt concentration. Diffusion of Alexa488 in 1 wt % dextran500, dextran20 (not 
shown), and dextran(-) solutions is essentially unaffected by added salt. Electrostatic 
interactions between probe and polymer solutions are not critical for these systems. In 
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contrast, the measured translational diffusion of negatively charged Alexa488 in 
dextran(+) was highly sensitive to added salt. With added salt, D is observed to increase 
greatly, reaching a plateau consistent with that for other dextran solutions, after which D 
is found to be independent of further added salt. From Figure 3.5, we see that the 
attractive electrostatic interactions between the negatively charged Alexa probe and the 
positively charged DEAE-dextran can be effectively screened out at ~125 mM added 
NaCl concentration. This salt range appears to be a characteristic crossover salt con- 
centration, suggesting that the system is near instability, and may function as a gating 
switch with ionic strength changes. 
 
 
Figure 3.5 FCS measured diffusion coefficient of Alexa488 in 1 wt % neutral and 
charged dextran solutions as a function of added NaCl salt concentration. Significant salt 
screening of the hindered diffusion of Alexa488 in dextran(+) is observed above ~125 
mM NaCl. (This figure is adapted from: Biophysical Journal Volume 108 February 2015 
530–539 with the permission from Biophysical Journal.) 
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3.3.4 Comparison of simulation and experiments  
Since Alexa488 has a net negative charge, the diffusion of Alexa488 particles in 
positively charged Dextran(+) can be compared to simulated particle diffusion in an 
attractive potential (i.e. U0<0).  Equivalently, the diffusion of Alexa488 in Dextran(-) can 
be compared to the simulation results with a repulsive potential (U0>0).  In order to do 
this, the interaction range k needs to be converted to an ion concentration CIon by use of 
equation (8). Furthermore, we need to gauge the simulation parameters p, the particle size, 
and b, the mesh size.  There is, to our knowledge, no definitive experimental data on the 
mesh size of a dextran hydrogel. Hence, we chose the particle diameter to be p=0.1 b in 
relative units and p=2.3 nm in absolute units. This value corresponds to the width of an 
Alexa488 molecule (1.5 nm), plus a water molecule (0.4 nm) and the width of a dextran 
monomer (0.4 nm) and it leads to an approximated mesh size of b=23 nm which is in the 
same order as reported estimations for the dextran mesh size at concentrations of around 
7 to 11 (w/v)%.112-113 
 Figure 3.6 shows a comparison between simulation and experimental data. 
Experimental data from FCS measurements is indicated by unconnected, filled symbols 
and the simulation data by connected points, where the lines are included to guide the eye.   
One can see that the simulation data and the experimental data are in good agreement. 
With an attractive potential of strength 𝑈0 = -8𝑘b𝑇, the theoretical model is in 
quantitative agreement with our experimental results for negatively charged Alexa488 in 
positively charged Dextran(+).  At low ionic strength, the attractive force dominates 
greatly reducing diffusivity.  As ion concentration increases, these attractive interactions 
are screened and the diffusivity increases up to a “saturation” point at around 100 mM 
ion concentration, where the diffusivity approaches that of the repulsive interaction data. 
To draw a similar comparison to the repulsive case of Alexa488 in negative dextran, we 
note that Dextran(-) has approximately one negative charge per 5 glucoses while the 
Dextran(+) has one positive amine group per 3 glucoses. This 60 % difference in charge 
density implies that the interaction potential strength should be taken as smaller for the 
repulsive case. To approximate this, we set the potential strength in the repulsive case to 
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𝑈0= +5kT, which corresponds to about 60% of the potential strength of the attractive case. 
In Figure 3.6 one can observe that the simulation and experimental data agree for all ion 
concentrations except towards small ones. Where in the experimental data 𝐷/𝐷uncharged 
remains constant towards decreasing 𝐶ion, the simulation data shows a slight decrease.  
The discrepancy could be caused by residual attractive hydrophobic or hydrogen-bonding 
interaction between the probe molecule and the polymer chain, which cancel the 
repulsive charge interactions, or by the polymer flexibility which is not included in the 
simulation model. 
 
 
Figure 3.6 Comparison between experimental results (unconnected, filled symbols) and 
simulation (connected points).  The diffusivity is shown over the total added ion 
concentration including the 10 mM due to the MES buffer and another 6 mM and 10 mM 
to take into account the ionic strength of the mobile ions which enter the solution upon 
addition of 1 wt% Dextran(-) and Dextran(+), respectively. Data was scaled by Duncharged, 
the diffusion coefficient measured at 1 wt% in the comparable molecular weight 
uncharged Dextran solution (D20 or D500). Simulations have been carried out at 
attractive (U0  = -8 kT) and repulsive potentials (U0  = 5 kT) for particles of diameter 
𝑝 = 0.1 𝑏 = 2.3 nm. Quantitative agreement between experiment and theory is observed. 
(This figure is adapted from: Biophysical Journal Volume 108 February 2015 530–539 
with the permission from Biophysical Journal.) 
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3. 4 Conclusion and future perspective 
The aim of this work was to examine nanoparticle diffusion in cross-linked hydrogels 
under consideration of nonsteric interactions between particle and hydrogel both 
experimentally and theoretically. FCS is a reliable tool for measuring diffusion of probe 
molecules in polymeric solutions. Transport properties of probe molecules in charged and 
uncharged gels were examined and compared to a simple theoretical model implementing 
a rigid, cubic periodic lattice designed to model the hydrogel structure and short range 
nonsteric interactions via an exponential potential between hydrogel polymer chains and 
diffusing particles. This model made it possible to perform BD simulations to examine 
key parameters in our system, including particle size, interaction strength, and interaction 
range. We found, both experimentally and theoretically, that the filtering capability of a 
hydrogel is strongly influenced by the sign of the interaction potential. Using a 
reconstituted model polymer system, we have shown that electrostatic interactions play 
an important role in governing the transport of charged probe molecules within charged 
hydrogels in a highly asymmetric fashion. This asymmetry with respect to charge is 
consistent with naturally occurring systems where the sign of the charge is significant in 
dictating the successful transport of molecules of interest through biogels.41-42 Attractive 
electrostatic forces between probe and network are much more effective than repulsive 
forces in hindering particle diffusion. In vivo, these particle-network interactions are 
likely to be significantly more complicated and are expected to depend on particle size, 
charge density, local charge distribution, and other factors, as has been suggested 
previously based on experiments of micron-size particles and charged peptides in 
reconstituted hydrogels.45, 80, 100, 114 Using a simple lattice model to perform BD 
simulations, we find quantitative near agreement between simulations and the 
experimentally determined diffusion of probe molecules in model charge networks. Our 
simulations reveal that the asymmetry between attractive and repulsive electrostatic 
interactions is due to the efficient sticking of particles to the vertices of the polymer 
network in the case of an opposite charge between particle and network. These results are 
also consistent with experiments on natural hydrogel networks, where nature appears to 
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use this charge asymmetry to filter and control the exchange of molecules between 
organelles and cells and their environments.42, 45, 100  
One limitation of our model is the rigidity of the network compared to the 
experimental hydrogel systems. Simulations predict a smaller but visible decrease in 
particle transport for similar charged probe-and-network systems that was not observed 
experimentally. A possible explanation for this is that a flexible network, unlike a rigid 
network, would allow the chains to bend away from the diffusing particle, thus reducing 
the effect on probe diffusion. The inclusion of flexible polymer chains will be addressed 
in future work, although we note that considerably longer simulation times will be 
necessary, making it more difficult to span the complete parameter space of such a more 
complex model. Previous experiments on the ECM, mucins, and the nuclear pore 
complex have shown significant differences in particle penetration depending on charge, 
and suggested electrostatic charge may enhance diffusion in biological hydrogels.41-42, 45, 
100 Our data suggest that electrostatics alone will not enhance diffusion through the 
network, indicating that charge-charge interactions are only part of the story for 
interaction filtering processes. To further refine our model, other nonelectrostatic 
interactions, including hydrodynamic and hydrophobic interactions, need to be included. 
Tuning these nonsteric interactions to control particle transport inside hydrogels may lead 
to greater understanding of molecular transport in vivo, as well as to more effective gel-
penetrating therapeutics.  
 
 
 
 
 
 
Copyright © Xiaolu Zhang 2015 
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Chapter 4 Diffusion of PAMAM dendrimers in neutral and charged hydrogels 
	
4.1 Introduction 
	
4.1.1 Nanocarrier transport in biological gels  
 Many nanomaterials have been designed for use as carriers to deliver molecular 
therapeutics to their intended targets. Nanomaterials offer several advantages as 
therapeutics due to their small size, large surface-to-volume ratio, ease of chemical 
modification and flexibility in molecular design.  Extensive efforts have been made to 
investigate the properties of nanocarrier-drug complexes to improve their solubility, 
permeability or targetability.115-116 For efficient use as a carrier, nanomaterials capable of 
reducing the toxicity and improving the solubilities of the drugs they bind are used.  
Typically excess nanomaterial is used to ensure complete drug encapsulation.  
Nanomaterial properties can be highly tailored; however, there are complex questions 
remaining regarding how these nanocarriers interact with biological systems. Surprisingly, 
only recently was there an appreciation that the nanocarriers themselves may increase 
possible risks to the patient due to their interactions in vivo.  There is a need therefore to 
understand the interactions between the carrier molecules and biological systems to 
optimize and guide the carrier design for therapeutic purposes.   
One major barrier in gene and drug delivery is that the engineered nanocarriers must 
traverse through complex crowded environments to reach specific loci in the target cells.  
The barrier functions of these biological hydrogels, including mucus, extracellular matrix 
and nuclear pore complex, present a tremendous challenge in achieving optimized 
effective treatment. Currently it is not fully understood how biomacromolecules in the 
system impact the mobility and transport of nanocarriers or nanocarriers-drug complexes. 
The physicochemical properties of nanocarriers and their interactions with biological 
hydrogels can be critical to determine the in vivo fate of the nanomedicines. Therefore a 
detailed knowledge of the diffusion behavior is required for engineering the next 
generation of delivery vehicles. 
 
 In this chapter, we focus on a common biocompatible nanocarrier system; 
polyamidoamine (PAMAM) dendrimers. PAMAM dendrimers are hyperbranched 
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cationic polymers which have shown great promise as a water soluble, polymeric carrier 
for a broad range of biomedical applications. Nanoparticle-biogel interactions may 
include many specific and nonspecific interactions; including electrostatics, chemical 
binding and hydrophobic/hydrophilic interactions. To gain insight into these complex 
systems, we will focus here on examining the transport properties within simpler model 
water-soluble polymer networks. PAMAM dendrimers are at the boundary between 
traditional polyelectrolytes and charged colloids.  The flexibility of the PAMAM polymer 
chains could influence their transport properties in ways inaccessible to hard colloids or 
the charged probe molecules studied in Chapter 3. Here we will discuss biophysical 
studies performed to better understand the importance of electrostatics on PAMAM 
transport in a reconstituted model hydrogel system that allows us to modulate the range 
and sign of the charge interactions. FCS experiments are performed to determine 
translational diffusion coefficients of a fluorescently labeled PAMAM (Alexa488-
PAMAM) in neutral and charged polymer solutions. FCS is unique in its ability to 
measure dynamic processes of small molecules in polymeric systems typically 
inaccessible by traditional diffusion measurements such as dynamic light scattering 
(DLS). Since FCS only requires nanomolar concentration, another key advantage is the 
minimization of particle-particle interactions between dendrimers as well as the intrinsic 
viscosity of the dendrimer solution.  
 
4.1.2 Unique properties of dendrimers 
 Dendrimers represent a class of macromolecules with unique chain architecture and 
properties. These unique attributes of dendrimers have made these molecules long 
considered one of the most promising nanocarriers for different therapeutic categories of 
bioactives. The term dendrimer is derived from the Greek word Dendron which means 
“tree.” Dendrimers are hyperbranched spherical macromolecules that are radially 
symmetrical around a core.117 As shown in Figure 4.1, the structure of dendrimer consists 
of three major components: (i) a central core, typically a molecule having at least two 
identical reactive chemical functions, (ii) interior dendritic branches extend outward from 
the core and are traditionally grown in a step-wise fashion. Every subsequent reaction 
step produces a new ‘generation’ of dendrimer resulting in an approximate doubling of 
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the molecular weight as well as a doubling of the surface functional groups.  The interior 
branch structure also includes internal void spaces, or ‘cavities’, which affect the host-
guest properties, (iii) an exterior surface populated with functional, terminal surface 
groups. The surface groups vitally determine the properties of dendrimers as well as the 
molecular interactions of dendrimers with drugs or biological environments. They are 
also active sites for further modifications.118  
 
Figure 4.1 Schematic representation of a third generation (G3) dendrimer.  Dendrimers 
consist of three major components: a central core, an interior dendritic branch structure 
(including internal void spaces or cavities), and an exterior surface populated with 
functional surface groups.  Dendrimers are grown in a step-wise manner from the core 
with each subsequent reaction step producing a new generation of dendrimer.  Each 
successive generation results in a dendrimer roughly twice the molecular weight of the 
previous generation with twice the number of surface functional groups (S). 
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 Dendrimers were first introduced by two different groups; Buhleier et al.119 and 
Tomalia et al.117 in the late 1970s and early 1980s.  PAMAM dendrimers are not only one 
of the first synthesized dendrimers, but also the first commercialized dendrimer and 
therefore represent the most well-known and studied dendrimer family.120 With the 
precisely controlled architecture and tunable surface groups, dendrimers offer a huge 
potential to be nanoengineered with favorable bioactivities.  Compared to other nanoscale 
synthetic structures like traditional linear polymers, metallic nanoparticles or carbon 
nanotubes, dendrimers have unique physical and chemical properties which offer 
significant advantages as discussed below. 
 
4.1.2.1 Monodispersity 
 Unlike traditional linear polymers, dendrimers have well-defined molecular structures 
and nearly monodisperse molecular weights. Their monodisperse nature has been widely 
verified by mass spectrometry, size exclusion chromatography, gel electrophoresis and 
transmission electron microscopy.121 PAMAM dendrimers, with appropriate synthesis 
and purification, have remarkably low dispersity for low dendrimer generations (e.g. G0-
G5). Even at higher generations, the molecular weight distribution still remains very 
narrow (i.e. polydispersity index, PDI = 1.05) even though imperfections or "branching 
defects" occur more frequently due to incomplete reaction products.120 Dendrimers 
therefore offer a controllable and consistent molecular weight parameter not typically 
possible in other synthetic nanomaterials, which is crucial to the run-to-run 
reproducibility. The ability to tailor surface functionality through dendrimer generation as 
well as post-synthesis modification also makes dendrimers highly promising nanocarrier 
candidates.  
 
4.1.2.2 Nanoscale size and shape 
 The size of dendrimers ranges from several nanometers to tens of nanometers 
increasing systematically with the generation number similar to many biomacromolecules. 
For instance, the diameters of PAMAM are calculated to range from 1.5 nm for G0 
PAMAM to 13.5 nm for G10.  PAMAM therefore represents a series of well-defined 
macromolecules that increase in diameter ~ 1 nm for each generation.122 Dendrimers’ 
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nanoscale sizes make it possible for them to cross biological barriers like membranes 
with the reduced risk of being prematurely eliminated by the immune system.118 The size 
of dendrimers is also relevant to their 3D shapes. Dendrimers are starburst polymers. 
Early generations of PAMAM (G0-G3) are flexible and open structures without well-
defined interior characteristics. Intermediate PAMAM generations (G4-G7) are thought 
to be more globular structures with defined interior structure due to geometric closure yet 
still containing a semi-flexible surface. These PAMAM dendrimers are believed to have 
accessible interiors to encapsulate drug molecules that are determined by the dendrimer 
generation nunber and properties of the surface groups. At higher generations (i.e. >G8), 
deGennes dense packing is severe and the interior structure is very rigid. With the highly 
dense packed branches, the interior of high generation dendrimers allows little access 
except for very small guest molecules.120, 123 
 
Based on the systematic size-scaling properties, dendrimers have been used as 
globular protein mimics. For instance, G3 PAMAM is the same size as insulin (diameter 
~ 3.0 nm) and G5 PAMAM is approximately the same size and shape as hemoglobin (Hb) 
(diameter ~5.5 nm).124 With the precise control of size, structure and surface chemistry, 
dendrimers are referred as artificial proteins in a variety of applications including 
diagnostics, gene delivery, molecular weight calibrators, enzyme mimics and site 
isolation.125 
 
4.1.2.3 Surface functional groups: density, charge and functionalization 
 Another key feature of dendrimers is the high density of surface functional groups. 
The number of terminal groups increases exponentially with each generation.  
Dendrimers may possess positive, neutral or negative charged surface functional groups 
for different biological applications. For instance, cationic dendrimers such as PAMAM 
can form complexes with negatively charged nucleic acids (NA) for use as a non-viral 
gene delivery vector.126-128 Positively charged dendrimer-NA complexes, or dendriplexes, 
have been shown to interact with biological membranes to enhance cellular uptake for the 
purpose of intracellular delivery while protecting the NA from extra- and intracellular 
nucleases. Further engineering and modification of the surface charge of the cationic 
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PAMAM through acetylation has also shown to be effective in tuning the ability of the 
carrier to deliver NAs as well as reduce cell toxicity.116, 129 Neutral or negatively charged 
dendrimers, such as PAMAM with PEGylated or carboxylated surface groups, can be 
engineered for binding of hydrophobic or cationic drug molecules, respectively, for use 
as a nanotherapeutic.  
 
The high density of functional surface groups facilitates multiple simultaneous 
interactions between the dendrimer and its environment.  This polyvalency of dendrimers 
is very important for biomedical applications as the multimeric binding of dendrimers is 
highly cooperative compared to monovalent systems.130-131 The multiple end groups can 
be precisely tailored and functionalized with various chemistries. The surface engineering 
strategy provides endless possibilities to design dendrimer as an engineered nanomaterial 
with favorable properties such as increased binding specificity and affinity.120 
 
4.1.3 Dendrimers in therapeutic applications, biomedical applications and 
diagnostic applications 
 Dendrimers with their easily controllable features like size, shape, and surface 
functionality, are considered to be one of most promising polymers in therapeutic, 
biomedical and diagnostic applications. Dendrimers are prepared with a level of control 
not attainable with most linear polymers, making them an ideal delivery vehicle 
candidate for explicit study of the effects of size, charge and composition on biologically 
relevant properties such as cell uptake, cytotoxicity and biodistribution. 
 
4.1.3.1 Dendrimers as drugs and as carriers for drug delivery 
 Based on the large number of peripheral groups, dendrimers alone have been 
investigated for their antimicrobial and antiviral properties. Cationic dendrimers and their 
derivatives are reported to show notable antimicrobial activity.132 With the 
interrelationship between generation number and dendrimer size and number of surface 
groups, dendrimers offer the possibility to explicitly study the effects of particle size and 
charge to optimize activity against prokaryotic membranes while minimizing eukaryotic 
toxicity.133 For instance, Cai et al. reported that G5 PAMAM showed high antibacterial 
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activity when exposed to Gram-negative bacteria strains (PA19660 and the clinical strain 
PA2219). Furthermore, reduced cation charge through partial surface functionalization of 
the PAMAM with PEG exhibited the same antimicrobial activity while greatly reducing 
the cytotoxicity of the dendrimer to human epithelial cells.132 Some dendrimers 
derivatized with peptides or anionic groups have also been shown to inhibit viral binding. 
One of the most successful examples is a sulfonated polylysine dendrimer called VivaGel 
that is used against HIV and currently undergoing phase I/II clinical trials.134  
 Because of their unique physicochemical properties, dendrimers are also well suitable 
as nanocarriers either encapsulating guest molecules in the interior or covalently binding 
drugs on the periphery.135 Dendrimers are known to act as unimolecular micelles, 
encapsulating hydrophobic drug molecules in their interior void space, therefore 
enhancing the solubility and bioavailability of drug compounds. Many common small 
molecule drugs are under risk of being filtered out by kidneys. The increase in particle 
size upon complexation in the dendrimer-drug complex helps the drug to exceed the renal 
threshold and extend circulation times in the bloodstream.134 Additionally, dendrimers 
show the potential to perform targeted drug delivery. For instance, dendrimers have been 
shown effective in the delivery of chemotherapeutic agents to passively targeted tumor 
cells by taking advantage of ‘the enhanced permeation and retention’ effect; the 
increasing uptake of large macromolecules in tumor tissue. Dendrimer-drug conjugates 
also exhibit slower release of the therapeutic, producing higher accumulation in solid 
tumors, and reduced systemic toxicity compared to the free anticancer drug.136 For 
instance, N. Malik et al. conjugated G3.5 PAMAM dendrimer to the classic anticancer 
drug cisplatin. The resulting dendrimer-platinate complexes exhibited slower release of 
the drug, higher accumulation in solid tumors and 3~5 fold less toxicity compared to bare 
cisplatin.137 
4.1.3.2 Dendrimers as gene delivery vectors 
 Dendrimer-based gene delivery is under active investigation in nonviral gene therapy 
approaches. Cationic dendrimers function as potential synthetic vectors that interact with 
plasmid DNA, oligonuclueotides, or siRNA, to form complexes that protect genetic 
materials from degradation and improve transfection efficiency into the nucleus.130, 138 
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The formation of nucleic acid (NA)-dendrimer complexes, or dendriplexes, is based on 
the ability of cationic dendrimers to condense the negatively charged nucleic acid (NA) 
phosphates. Dendriplexes are subsequently taken up by cells by endocytosis and 
transferred from cytoplasm to nucleus followed by NA release resulting in transcription 
processes and target protein translation.139 Cationic dendrimers, particularly amine 
terminated dendrimers such as PAMAM or polypropylenimine (PPI), or polylysine 
dendrimers, have been reported to enhance the transfection efficiency both in vitro and in 
vivo. Generally, high generation dendrimers with sufficiently high nitrogen to phosphate 
(N/P) charge ratios correlate with better cellular uptake. For PAMAM, efficient 
transfection is generally limited to generations > 4.140 Like most polyamines, the high 
surface charge of the dendrimers does result in a charge- and concentration-dependent 
cytotoxicity profile. Surface modifications, such as grafting polyethylene glycol (PEG) 
groups or acetylation, which result in a partial reduction in the PAMAM surface charge 
have been shown to reduce the cytotoxicity while maintaining transfection efficiency. For 
instance, D. Luo et.al showed that G5 PAMAM modified with 3400 Da PEG had low 
toxicity yet was able to produce a 20-fold increase in transfection efficiency compared 
with partially degraded dendrimer controls.141 
 
4.1.3.3 Dendrimers as diagnostic agents 
 Through linking to various ligands, dendrimers are also promising candidates for 
diagnostic applications such as molecular detection, radiotherapy and as imaging 
agents.142 For example, dendrimers have been used as contrast agents in magnetic 
resonance imaging (MRI) - a standard method of imaging associated with cancer 
diagnoses. Gadolinium chelates like Gd(III)–diethylenetriaminepentaacetic acid(Gd-
DTPA) are currently the most widely applied contrast agents for clinical MRI since they 
have a different relaxation time in diseased and normal tissue.143 The biggest shortcoming 
of these agents is that they are excreted from the body very rapidly because of their low 
molecular weight. To improve upon this drawback, macromolecules like poly(amino 
acids), polysaccharides, and proteins have been conjugated to Gd(III) to enhance the 
circulation time and improve the image contrast. The limitation of many of these 
macromolecular agents however is their potential toxicity from the accumulation of 
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released Gd(III) ions in the body. Hence, dendrimers, with the appropriate, well-defined, 
and controllable structure, are ideal macromolecules to form complex with Gd. 
Dendrimer-based Gd(III) chelates  have been reported to have strongly increased 
relaxivity and circulation time.144 Moreover, the undesired retention time and potential 
risk of Gd release can be reduced by modification of surface functional groups through 
dendrimer PEGylation.145 
 
4.1.4 Challenges and our research motivation  
 To date, dendrimers have achieved significant success and shown great promise in a 
variety of pharmaceutical and biomedical applications. Dendrimers offer a very high 
degree of molecular control and represent ideal carriers for structure-activity studies to 
determine the explicit effect of polymer size, charge and composition on biologically 
relevant properties. Most uses require that these dendrimers, or their dendrimer-
therapeutic complexes, traverse complex biological hydrogels such as the ECM to reach 
their cell targets. Despite extensive studies of the physicochemical properties of 
dendrimers, little is currently known about the structure and dynamics of dendrimers 
inside biological gels.146 Many important questions remain: How do the dendrimers 
transport themselves or their cargos in biological fluids? How do the dendrimer-gel 
interactions influence their diffusion behavior or the permeability of biological gels? To 
begin to address these questions, we used FCS experiments to determine the translational 
diffusion coefficient of PAMAM dendrimers in uncharged and charged polymer solutions.  
Such mechanistic and systematic studies to determine the effects of particle-network 
interactions on dendrimer dynamics in vivo may lead to a greater understanding of how to 
tune these nonsteric interactions to optimize molecular transport and molecular release of 
dendrimer-based medicines and produce more effective gel-penetrating therapeutics. 
 
4.2 Methods and materials 
	
4.2.1 PAMAM characterization and labeling 
Polyamidoamine (PAMAM) dendrimers (Generation 5, ethylenediamine core, amine-
terminated and 5 wt% solution in methanol) were obtained from Sigma Aldrich (St Louis, 
	 57	
MO).  Before use, methanol was removed under reduced pressure at room temperature 
using a Labconco Centrivap Centrifugal Vacuum Concentrator. G5-PAMAM were 
subsequently dissolved in deionized water and buffered with 10 mM MES buffer and 
titrated with acid or base to the desired final pH of 6.4. This pH is sufficient to maintain 
the full protonation of the PAMAM surface functional groups.   
 
 For FCS experiments, PAMAM was labeled with amine reactive Alexa Fluor®488 
Succinimidyl Ester purchased from Invitrogen. To minimize the effect of the dye 
molecule on the PAMAM dynamic behavior the reactants mole ratios were controlled to 
result in a PAMAM:Dye ratio of ~1:1. Following the protocol, the labeling chemical 
reaction was carried out in sodium bicarbonate buffer solution (0.2M pH=7.5). Labeled 
G5 PAMAM was purified by disposable PD-10 Desalting Columns (GE Health care Life 
Sciences) to remove the free dye and buffered subsequently in MES.  Slightly higher 
labeling ratios were examined (PAMAM: Dye of ~1:2 and 1:4) with no significant effect 
on the FCS measured  translational diffusion coefficients and hydrodynamic radius.  
 
4.2.2 Preparation of polymer solutions 
 To study PAMAM diffusion in polymer gels, charged and uncharged dextran polymer 
solutions were used. Dextran (MW = 15-25 kDa), Dextran (MW = ~500 kDa), 
Carboxymethyl-dextran (CM-dextran(-))(MW = 15-20 kDa) and diethylaminoethyl-
dextran (DEAE-dextran(+))(MW=~500 kDa) were all purchased from Sigma Aldrich.  
To remove salts and contaminants, all polymer solutions were extensively dialyzed 
against Milli-Q water and then lyophilized before use.  Purified polymer solutions were 
then redissolved in MES buffer (10 mM, pH 6.4) to make the desired percent w/v dextran 
solutions and stirred overnight. Fluorescently labeled dendrimer was added into dextran 
solutions and the final concentration was retained to be ~10 nM. All the samples were 
incubated at room temperature for more than 12 hours to ensure the fluorescent 
molecules had enough time to disperse uniformly throughout the sample. 500 µL sample 
from each individual solution was loaded into 8 well NUNC sample holders and 
measured by FCS at room temperature. 
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4.2.3 FCS setup and data analysis 
 FCS experiments were made using an ISS Alba confocal fluorescence fluctuation 
system (Urbana, Il) coupled to a Nikon Ti-U microscope equipped with a 60×1.2 NA 1.2 
water immersion objective lens. The illumination source was a continuous-wave 488 nm 
laser diode. The emission signal for the 488 nm was passed through a 514 nm long-pass 
edge filter before detection. Emission signal was recorded by two separate 
photomultiplier tubes (PMTs). All FCS measurements were performed in NUNC LabTek 
8-well microscopy chambers (Nalge Nunc) with a final volume of ~500 µL.  
Determination of the focal volume was established via calibration against an aqueous 
solution of rhodamine 110 (D = 440 µm2 s-1).  FCS results are an average of at least 20 
measurements, taken at various positions within the polymer solutions to ensure 
homogeneity, with typical sampling times of 30 s. All results are expressed as the mean ± 
SD of the measured diffusion coefficient. FCS measurements were analyzed using 
VistaVision 4.0 software. 3D-Gaussian one-component and two-component fitting 
models, as described in chapter 2, were used for data analysis. 
 
 As the basic principles of FCS have been described in detail in chapter 2, we give 
only a brief overview here. FCS measures the fluorescence fluctuations emitted from 
labeled molecules moving in and out of a small confocal volume (~1 fL). The size of the 
effective illumination volume is fixed by the confocal detection optics and the excitation 
profile of the focused laser beam and characterized by measurements against a standard 
of a known diffusion constant. For ideal particles of uniform size diffusing by Brownian 
motion, dynamic information can be determined from the intensity fluctuations by means 
of a time autocorrelation given by  
𝐺(τ) = !
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)!/!.                                           (1) 
Here, N is the average number of particles in the illumination volume and the structure 
parameters r0 and z0 are the axial and radial dimensions of the excitation beam 
determined by calibration measurements against a known standard.  
 When there are two species in the system but no interaction between them, the 
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diffusion times for each of the species are independent. Considering the contribution of 
particles for each component the correlation function leads to60, 62 
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which N1 and N2 are average numbers of particles of each component. 𝜏!! 𝑎𝑛𝑑 𝜏!! are 
the independent diffusion times of two components crossing the illumination volume 
described by its structure parameter 𝜔 (𝜔 = 𝑟!!/𝑧!!). 
 
 The autocorrelation can then be normalized by 
𝐺!"!" 𝜏 =
!(!)
!(!)
                                                          (3) 
 The diffusion time, τD, is related to the translational diffusion coefficient D by the 
simple relationship 
 τ! =
!!!
!∙!
                                                                (4) 
where D denotes the translational diffusion coefficient of the molecules in solution and is 
calculated from the lateral dimensions of the focused incident beam and the 
experimentally determined τD. For spherical particles, the diffusion coefficient D follows 
from the hydrodynamic radius, rh, in solution and can be calculated by the Stokes-
Einstein relation D=kBT/6πηrh, where kB is the Boltzman constant, T is the temperature, 
and η is the viscosity of the medium. 
 
4.2.4 DLS and zeta potential measurement 
PAMAM was dissolved into 10 mM MES buffer to a final concentration of 1 mg/mL 
for hydrodynamic measurements by dynamic light scattering (DLS).  DLS measurements 
to determine the hydrodynamic radius of the dendrimers were performed with a 
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NanoBrook 90Plus Particle Size Analyzer (Brookhaven Instruments Corporation) at 25°C 
with a  fixed scattering angle of 90°.  Zeta Potential was measured in MilliQ water with a 
ZetaPALS Zeta Potential Analyzer (Brookhaven Instruments Corporation) at room 
temperature. Each data point was an average of at least 4 runs and the results are 
expressed as mean ± SD. 
 
4.3 Results and discussion 
	
4.3.1 Dendrimer labeling and purification 
 To make the PAMAM molecules suitable for FCS measurements, we chose Alexa 
Fluor 488 succinimidyl ester as a label to react with the primary amine groups on the 
surface of PAMAM. It is important to examine if the dendrimer molecules have been 
successfully labeled and sufficiently purified as well as ensuring no undesired side 
reactions, such as aggregation, occurred during the labeling reaction; both measurements 
ideally suited for FCS investigation.  
 Labeled PAMAM was separated from free dye by gel chromatography using a double 
PD-10 column. Fractions of 200 µL were collected and examined by FCS. There were 
two detectable fractions: free dye (f1) and labeled PAMAM (f2) with their respective 
diffusion coefficients (Df1 and Df2). Listed in Table 4.1 are the experimentally determined 
diffusion coefficients and hydrodynamic radii for the various fractions.  All fractions 
were fit with either a one-component or two-component fit resulting in a best fit for the 
measured autocorrelation function. rh represents hydrodynamic radius calculated from the 
Stokes-Einstein relation. From Table 4.1, it is clear that the first two fractions from size 
exclusion separation are purified, Alexa labeled PAMAM. The autocorrelation curves are 
best described with a one-component fit resulting in diffusion coefficients and rh values 
in good agreement with the theoretical G5 PAMAM radius (2.7 nm). No evidence of 
significant unreacted free dye is observed. Subsequent separation fractions are only 
described by a two-component fit with a mixture of a fast component (unreacted free dye) 
and a slow component (labeled PAMAM). The final separation fractions show only 
unreacted free dye molecules and again have measured autocorrelation functions best 
described by a one-component model (equation 1).  Representative FCS autocorrelation 
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curves (symbols) with their corresponding fits (solid lines) are shown in Figure 4.2. The 
labeled PAMAM has a much longer diffusion time indicating its distinct size difference 
from free dye. The fraction 7 sample is identical to the standard Alexa488 solution 
measured independently. The fraction 1 sample is well described by a one component fit 
suggesting that labeled PAMAM was successfully purified from excess free dye 
molecules. No significant aggregation is observed by FCS.  
 
Table 4.1 Translational diffusion coefficients (D) and calculated hydrodynamic radii (rh) 
of each fraction after PD-10 column purification. Df1 represents diffusion coefficient for 
free dye.  Df2 represents the diffusion coefficient for labeled PAMAM. For fraction 
1,2,5,6 and 7 the diffusion coefficients were determined by using one-component model 
as equation 1. For fraction 3 and 4, the Df1 and Df2 were determined by using two-
component fitting model as equation 2. 
 
Fraction Df1 (µm2/s) rh(nm) Df2 (µm2/s) rh(nm) 
1 N/A N/A 91.8 2.6 
2 N/A N/A 78.6 2.9 
3 267.6 0.8 85.9 2.7 
4 240.9 0.9 87.6 2.7 
5 280.5 0.8 N/A N/A 
6 286.0 0.8 N/A N/A 
7 294.5 0.8 N/A N/A 
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Figure 4.2 Normalized FCS autocorrelation curves for Alexa488 solution (open square), 
fraction 1 (open triangle) and fraction 7 (open circle) from Alexa488 labeled PAMAM 
after purification on a PD-10 column. Solid lines represent fits to the experimental data 
by equation 1. 
 
 To minimize the effect of the dye labeling on the dynamic properties of the PAMAM 
molecules and its interactions with biological gels, we needed to carefully control the 
labeling ratio. G5 PAMAM has 128 primary amine groups on the surface which offer 128 
active sites for labeling reaction. By tuning the molar ratios of PAMAM:dye, we were 
able to approximately control the amount of labeling per PAMAM.  PAMAM:Alexa488 
ratios of 1:1, 1:2 and 1:4 were synthesized. Only slight changes in the PAMAM diffusion 
time, and thus hydrodynamic radii, were observed by FCS with increasing ratio of dye 
molecules. This is shown from the normalized autocorrelation curves in Figure 4.3.  
However, all were clearly distinguishable from free dye showing that all reactions did 
result in labeled PAMAM. The measured diffusion coefficient and calculated 
hydrodynamic radii are listed in Table 4.2.  Reactions resulting in approximately one dye 
per PAMAM had the least increase on the measured PAMAM size compared to the 
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theoretical radius. With more dye attached, the measured size of PAMAM gets slightly 
larger. To achieve minimal interference on PAMAM surface, the 1:1 labeling reaction 
samples were used for all the following experiments. 
 
 
Figure 4.3 Normalized FCS autocorrelation curves for standard Alexa488 solution and 
G5 PAMAM with different labeling ratios. Solid lines represent fits to the experimental 
data by one-component model as equation 1. 
 
 
Table 4.2 Diffusion coefficients (D) and calculated hydrodynamic radius (rh) of alexa488 
labeled G5 PAMAM with different labeling ratios. 
 
Labeling ratio D (µm2/s) rh (nm) 
1:1 89.2±2.9 2.6±0.1 
1:2 81.5±4.4 2.8±0.1 
1:4 75.3±3.9 3.0±0.1 
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4.3.2 PAMAM diffusion in uncharged polymer solutions 
 To study the steric effects on dendrimer diffusion in hydrogels, we first investigated 
the diffusion of G5 PAMAM in uncharged polymer.  The polymer networks were 
maintained in 10 mM MES (pH 6.4) to ensure complete protonation of all of the G5 
PAMAM primary amines on the dendrimer surface. Figure 4.4 shows the scaled 
translational diffusion coefficients (D/D0) as determined by FCS as a function of three 
different uncharged polymer solution concentration. D0 is the translation diffusion 
coefficient of G5 PAMAM in MES buffer without the polymer. As expected, the 
diffusion coefficients (D) decrease with increasing polymer concentration due to steric 
effects. Diffusion is hindered the most in the highest molecular weight, and thus most 
viscous, polymer solution (500 kDa dextran).  PAMAM diffusion in the similar ~20 kDa 
PEG and dextran solutions are nearly identical.  
Several different physical models based on hydrodynamic and steric interactions have 
been used to model particle diffusion in uncharged networks.  While the different models 
start with different physical phenomena, most models derive equations that describe 
nanoparticle diffusion in the form of a stretched exponential. Solid lines in Figure 4.4 
depict best fits to the data using D=D0 exp(-αcn) where D0 is the particle diffusion in pure 
solvent, c is the polymer concentration and α and n are constants dependent on the 
particle-gel system. As discussed in chapter 3, n is thought to reflect the polymer solvent 
quality while α is dependent on system parameters such as particle size and molar mass. 
Fitting parameters α and n are listed in Table 4.3. All the n values are in a narrow range 
close to n=0.75 which corresponds to good polymer solvent quality in water. α values for 
PAMAM in 20 kDa PEG and dextran are very similar but significantly increases in value 
for PAMAM in 500 kDa dextran solution suggesting that α has a dependence on the 
polymer molecular weight in agreement with the Phillies’s model.93 Compared to the 
results from probe diffusion project (Table 2.1), the α and n values for PAMAM diffusion 
are more similar to the values for larger macromolecules like phycoerythrin rather than 
small probe dye molecules. This simply suggests that these large macromolecules 
experience different local dynamics from small probe molecules as we would anticipate 
for particles that have sizes closer in size to the gel correlation lengths. 
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Figure 4.4 Scaled diffusion coefficients of G5 PAMAM as a function of the 
concentration of different molecular weight non-charged polymer solutions (PEG 20 kDa, 
dextran 20 kDa and dextran 500 kDa). Solid lines are fits of the data with the stretched 
exponential D=D0 exp(-αcn), where α and n are fitting parameters.  
 
 
Table 4.3 Exponent and prefactor values determined from best fits of D=D0 exp(-αcn) to 
data for G5 PAMAM diffusion in hydrogels. 
Gel solution α n 
PEG 20kDa 0.33 0.81 
Dextran 20kDa 0.38 0.84 
Dextran 500kDa 0.56 0.72 
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4.3.3 PAMAM diffusion in charged polymer solutions 
 To investigate the electrostatic interaction on PAMAM transport in polymer networks, 
we next measured the translational diffusion coefficients of G5 PAMAM within charged 
polymer solutions. G5 PAMAM has 128 primary amine groups (pKa~9.2)147 on the 
surface.  In MES buffer (pH 6.4), we would therefore anticipate each dendrimer molecule 
to carry a net +128 charged sites.  Here, the charged polymer solutions are dextran(+) 
(DEAE-dextran) and dextran(-) (CM-dextran) as discussed in chapter 3. The charged 
dextran solutions have significant molecular weight differences and are thus compared to 
PAMAM diffusion in similar MW uncharged dextran.  
 Normalized autocorrelation curves of the cationic Alexa488-PAMAM in the cationic 
DEAE-dextran are shown in Figure 4.5 as function of the polymer concentration. 
Comparable with probe molecules studied in chapter 3, Figure 4.5 reveals that in gels 
with the same charge as the PAMAM molecules, the characteristic diffusion time (τ) of 
the PAMAM increases significantly compared to MES buffer. This shift in the diffusion 
time reveals that in gels of the same charge as the dendrimer, the mobility of the 
PAMAM is significantly reduced.  τ shows only weak dependence on increasing 
dextran(+) concentration.  Translational diffusion coefficients, D, as determined by 
equation 4, are shown in Figure 4.6 for G5 PAMAM in 1-8 w/v% Dextran (+) solution. 
Compared with values of PAMAM diffusing in uncharged dextran of comparable 
molecular weight (500 kDa Dextran), the measured diffusion coefficients are greatly 
reduced due to electrostatic repulsions rather than steric effects.  Based on our previous 
Brownian dynamic simulations of probe molecules in like-charged gels, we hypothesize 
that the highly positively charged PAMAM molecules in this repulsive regime would 
undergo a “trapping” effect where the like charges of the polymer network changes 
confine the PAMAM particles within smaller regions inside the hydrogel. The repulsive 
forces form a “cage effect” limiting the space available for the PAMAM molecules to 
access thus slowing down their diffusion within the biogels.   
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Figure 4.5 Normalized autocorrelation curves of G5 PAMAM in 10mM MES buffer, 1%, 
4% and 8% DEAE-Dextran(+) solutions. Solid lines represent fits to the experimental 
data by one-component model as equation 1. 
 
 
Figure 4.6 Diffusion coefficients determined by FCS of G5 PAMAM as a function of 
DEAE-Dextran(+) solution concentration. 
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 Figure 4.7 shows the normalized autocorrelation curves of the cationic PAMAM in 
buffer, 1%, 4% and 8% dextran(-) solutions; an attractive electrostatic regime.  Here, we 
anticipated the PAMAM molecules to “stick” to the polymer network leading to a 
stronger immobilization of the dendrimer molecule and ultimately a significantly greater 
reduction in the particle dynamics within the gels.  Instead, however, we observe that the 
characteristic diffusion time (t) of the PAMAM decreases even compared to MES buffer 
for all Dextran(-) concentrations.  Figure 4.8 shows the diffusion coefficients of G5 
PAMAM as a function of Dextran(-) solutions. Surprisingly PAMAM does not appear to 
have hindered diffusion due to sticking like the smaller, hard sphere, probe molecules but 
rather the apparent diffusivity of PAMAM is significantly enhanced in this oppositely 
charged system.  
 
Figure 4.7 Normalized autocorrelation curves of G5 PAMAM in MES buffer, 1%, 4% 
and 8% CM-Dextran(-). Solid lines represent fits to the experimental data by one-
component model as equation 1. 
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Figure 4.8 Diffusion coefficients of cationic G5 PAMAM as a function of Dextran(-) 
polymer concentration.  
 
 Together, these results suggest the electrostatic interactions between PAMAM 
molecules and polymer matrix clearly impact the dynamic behavior of PAMAM. 
Moreover, PAMAM showed completely opposite behaviors in positively and negatively 
charged hydrogels. To further understand these significant differences we next will 
investigate the effect of added salt on the PAMAM diffusion.  
 
4.3.4 Salt effect on PAMAM-hydrogel interactions 
 Any electrostatic effects between diffusing particle and network would be expected to 
be strongly dependent on salt due to the Debye screening of the electrostatic interactions. 
It is therefore important to know how the ionic strength affects the transport properties of 
PAMAM in these charged gel networks. In Figure 4.9, the diffusion coefficient (D) of G5 
PAMAM in 1 wt % dextran(+) is plotted as a function of added NaCl concentration.  As 
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shown in Figure 4.5, 1 wt% dextran(+) was sufficient to greatly reduced the translation 
diffusion coefficient compared to MES buffer alone. Here, we see the measured 
translational diffusion coefficient of the cationic PAMAM is highly sensitive to added 
salt.  It increases greatly, reaching a plateau at about 75 mM NaCl in solution, after which 
D is seen to be independent of further added salt.  This diffusion coefficient at the plateau 
is approximately the same as the measured D of PAMAM in a similar molecular weight 
uncharged dextran solution. This suggests the hindered diffusion of cationic PAMAM in 
dextran(+) is due to electrostatic repulsion within the network.  As expected, this “caging” 
effect is eliminated with the addition of added salt up to a characteristic crossover salt 
concentration as the repulsive electrostatics between PAMAM and network are screened 
out.   
 
  
Figure 4.9 Diffusion coefficients of G5 PAMAM in 1% DEAE-Dextran solution as a 
function of added NaCl concentration. 
 
 In the case of attractive electrostatics, here where the cationic PAMAM is diffusing in 
dextran(-), Figure 4.10 shows the diffusion coefficient of cationic PAMAM in 1 wt % 
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dextran(-) solution as a function of salt concentration. As shown in Figure 4.7, 1 wt % 
dextran(-) results in a significant increase in the translation diffusion coefficient of 
PAMAM faster even than diffusion in buffer alone. Here, we see with added salt the 
measured diffusion coefficient D is unaffected by adding salt. This suggests the mobility 
of PAMAM in an electrostatically attractive network is independent of charge. It is noted 
that the measured diffusion coefficients of PAMAM, in both positively and negatively 
charged networks with high salt concentration, are greater than it in MES buffer solution 
consistent with steric effects due to the presence of the 1% polymer solution. 
 
 
Figure 4.10 Diffusion coefficients of cationic G5 PAMAM in 1% CM-Dextran(-) 
solution as a function of added NaCl concentration. 
 
 To further parse the effect of salt on PAMAM diffusion we measured salt effects on 
PAMAM dynamics in uncharged polymer as well as buffer. Figure 4.11 shows the 
measured diffusion coefficients (squares) of G5 PAMAM in 10 mM MES buffer (pH 6.4) 
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as a function of added salt concentration.  The corresponding hydrodynamic radius 
(circles) are also plotted in Figure 4.11 as calculated from Stokes-Einstein equation.  
Here we see both D and Rh plateau at a critical salt concentration of ~30-40 nM added 
salt.  The reduction in the apparent hydrodynamic radius suggests a conformation change 
of the PAMAM in the presence of salt to a much more compacted form. Such compaction 
of the PAMAM has been predicted previously from MD simulations due to the ability of 
the PAMAM chains to fold into the internal cavities of the dendritic structure.148-150 
 
 
Figure 4.11 The measured translational diffusion coefficient, D, of G5 PAMAM in 10 
mM MES buffer as a function of added NaCl concentration. Rh is the corresponding 
hydrodynamic radius calculated by using Stokes-Einstein equation. 
 
 We examined PAMAM diffusion in uncharged dextran solutions comparable to the 
charged dextran molecular weights (20 kDa and 500 kDa respectively). Figure 4.12 
shows the dependence of D for G5 PAMAM in neutral dextran as a function of added salt.  
Again the translational diffusion coefficient measured by FCS increases with added salt 
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reaching a plateau at about ~60-70 mM added NaCl similar to the crossover salt 
concentration observed in charged dextrans.  This result confirms the increase in D is 
independent of any steric effects though the maximal D reached depends on the 
molecular weight of the Dextran. 
 
 
Figure 4.12 The diffusion coefficients of PAMAM in 20 kDa and 500 kDa uncharged 
dextran solutions as a function of added NaCl concentration. 
 
 To characterize the potential property change of PAMAM with addition of salt, we 
applied zeta potential analysis to examine the surface charge of PAMAM molecules. 
Measured zeta potential (ζ) plotted as a function of added salt concentration is shown in 
Figure 4.13. G5 PAMAM in MES buffer solution (10 mM, pH=6.4), gives high positive 
zeta potential values (＞25 mV) indicating that PAMAM molecules carry significant 
positive charge on the surface and remain stable in the solution.151 The measured zeta 
potential decreases significantly with added NaCl reaching ~ 0 by 60-70 mM NaCl 
concentration.  This result suggests the surface charge of PAMAM is effectively screened, 
	 74	
or partially screened, by chloride ions. When the salt concentration reaches to ~60mM，
the surface net charge is approximately zero.  
 
Figure 4.13 Zeta potential of G5 PAMAM in 10 mM MES buffer solution (pH 6.4) with 
different sodium chloride concentrations. 
 
 In MES buffer (pH=6.4), the primary amine groups on the surface of PAMAM are all 
protonated and repel each other to form more like an open and spherical structure. This 
repulsive force can be screened out by adding salt into the system and makes the 
branches on the dendrimer more flexible and results in a compaction of the dendrimer to 
a significantly smaller hydrodynamic radius compared to the normal charged PAMAM. 
Thus, the chain flexibility of the PAMAM gives rise to new behavior not observed in 
hard sphere particles.  PAMAM in polymer networks of the same charge can get caged 
by electrostatic repulsions between the chain and polymer and show a slowing down of 
their diffusion coefficients.  This electrostatic effect can be screened out with salt.  
PAMAM in an attractive electrostatic network shows a great increase in the PAMAM 
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diffusion coefficient.  This increase in D is independent of added salt.  PAMAM in 
uncharged networks and in buffer also show an increase in D with added salt suggesting a 
conformational collapse.  The final D measured by FCS for PAMAM in uncharged 
polymer networks is very similar to the D measured PAMAM/Dextran(-) measurements.  
Combined these results suggest that PAMAM size is highly dependent on salt 
concentration. In addition, these results suggest the increase in D observed for PAMAM 
in an oppositely charged polymer network arises due to the network itself acting as a 
large counterion to the PAMAM molecule resulting in a situation equivalent to PAMAM 
in salt. 
 
4.4 Conclusions and future perspective 
 The purpose of this study was to investigate the role of electrostatic interaction in the 
transport of a highly charged and flexible PAMAM macromolecule in hydrogels. The 
diffusion coefficients of G5 PAMAM in both uncharged and charged polymer networks 
were measured by FCS and the diffusion behaviors are distinct. PAMAM diffusion in 
neutral gel is hindered due to sterics. PAMAM transport in like-charged polymer 
networks results in a much more hindered diffusion of the particles. This diffusion 
hindrance was screened out with the addition of salt suggesting it is electrostatic in nature.  
Most likely this scenario is a similar “caging” effect observed in Brownian dynamic 
simulations of probe molecules in like-charge polymer networks.  For PAMAM in gels of 
opposite charge, an attractive electrostatic situation, a new behavior is observed.  The 
diffusion coefficient of the PAMAM increases significantly and is faster than the 
diffusion of the PAMAM in water. This increased diffusion is independent of added salt 
concentration.  Studies of salt effects on PAMAM diffusion in buffer and in neutral gels 
also show an increased diffusion coefficient with added salt. This suggests that with 
added salt, the repulsions of the surface functional groups are screened and the PAMAM 
collapses to a more compacted conformation with a significantly reduced hydrodynamic 
radius. Several recent theoretical studies suggest the conformation of PAMAM is rigid 
and cannot be modulated by electrolytes with low salt concentration or changes in pH.152-
153 These studies are consistent with recent small-angle neutron scattering (SANS) 
measurements, performed at relatively high PAMAM concentrations, that showed little 
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change in PAMAM size with pH. However, other recent experimental studies have 
shown the swelling and deswelling of PAMAM, especially of intermediate generation 
number, at different pH consistent with early theoretical studies. These studies argue that 
PAMAM is flexible with the deprotonation of surface groups able to cause the surface 
branches to back-fold resulting in a more compacted state with a smaller hydrodynamic 
radius and greater diffusivity.154-158 Our FCS results of PAMAM in buffer and in neutral 
polymers, at very low dendrimer concentrations not typically accessible experimentally, 
also suggest a significant compaction of the PAMAM with added salt up to a critical salt 
concentration where no further compaction is observed.  We note that the increased 
diffusivity of the PAMAM in oppositely charged polymer networks results ultimately in a 
diffusion coefficient nearly identical to PAMAM diffusing in a comparable molecular 
neutral dextran polymer solution.  We hypothesize that the oppositely charged polymer 
network may therefore be acting as a large counterion resulting in a similar PAMAM 
compaction within the hydrogel.  Taken together, our results reveal the essential role of 
electrostatic interaction in nanoparticle transport through biological hydrogels especially 
for highly charged and flexible polyelectrolytes.  The potential of dendrimers as 
drug/gene delivery vectors suggest this behavior is essential to understand how best to 
optimize the therapeutic benefits of dendrimers as nanocarriers especially inside biogels.  
As the structural compaction is believed to be dependent on the PAMAM generation 
number, future studies should include looking at the generation dependence on the salt-
induced compaction of PAMAM. Low generation PAMAM would have short branches 
with open, ill-defined internal structure and would not be expected to compact greatly.  
High generation PAMAM would also not be expected to be able to compact significantly 
due to the highly rigid dense packed structures. Maximal compaction would be 
anticipated for the intermediate generations (like G5) used in this study.  In addition, we 
used only one type of PAMAM functional surface chemistry; an amino group.  
Comparison of PAMAM behavior modified with COOH groups (- charge) or PEG 
(neutral) would further elucidate the details of the electrostatic interactions in controlling 
PAMAM-biogel interactions.  Our current results, suggest we should see the same results 
for the negative charged PAMAM in either attractive or repulsive networks.  We would 
anticipate only steric effects for neutral PEGylated PAMAM.  As discussed in the 
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introduction, the high level of molecular control of dendrimers make them ideal 
candidates for nanomedicines including drug and gene delivery vehicles.  Additional 
future studies could examine transport of PAMAM-gene or PAMAM-drug complexes to 
determine the role of electrostatics on complex penetration as well as therapeutic release 
within charged polymer networks.  Such experiments would help further elucidate the 
mechanism and kinetics of the release within dendrimer nanocarriers and what role the 
biogel plays on this release. 
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Chapter 5 Corona formation and binding kinetics of albumin and transferrin to 
polystyrene nanoparticles 
 
5.1 Introduction 
 It is increasingly accepted that with the rapid growth of nanotechnologies, situations 
where engineered nanomaterials (ENMs) will interact with biological systems will 
continue to rise.  Interactions between nanomaterials and living matter play an essential 
role in governing their potential efficiencies and toxicities. Hence, understanding the 
molecular interactions of ENMs with living matter is emerging as a key objective for 
their safe and efficient biomedical application. In the biological milieus, nanoparticles 
typically are modified by adsorption of biomolecules, commonly proteins, due to their 
large surface areas.  This protein layer or ‘protein corona’ ultimately defines the 
biological identity of the nanoparticle surface. In general, the nature of ENM surfaces 
(material character) dictates the formation of the corona – or, in a biological context, 
“what the cell sees” during, e.g., drug delivery. Thus we predict the corona therefore 
governs the biological response of the body to the ENM and thus also ultimately 
determines the biodistribution and in vivo fate of the nanoparticles.159-163  
 
 In the body, the formation of the protein corona is a complex, dynamic process and 
depends on many parameters. There is no one “universal” plasma protein corona for all 
nanomaterials. The amount and presentation of the proteins on the surface of the 
nanoparticles is not correlated simply to the protein relative abundances in the biological 
fluid and appears to be unique to each type of ENM and the physiological conditions.164 
Factors that control the structure and composition of the corona include (i) the 
physicochemical properties of the nanoparticle such as size, shape, terminal groups and 
surface charges, (ii) the exposure time of nanoparticles in biological fluids and (iii) nature 
of the physiological environment.160, 164 Protein-nanoparticle interactions govern the 
formation of the protein corona that then endows the nanoparticles with new biological 
identities that differ greatly in surface composition from their engineered surface in the 
pristine state.161, 165 It is increasingly believed that the identity of ENMs, and their in vivo 
fate and effects, are ultimately determined by the biomolecular corona formed as they are 
exposed to complex media.  Controlled transport distribution of ENMs through biological 
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fluids and in cells is crucial to many potential applications.  There is a critical need 
therefore for a quantitative knowledge of the creation of protein coronas on nanoparticles 
as well as the dynamic and kinetics of the corona formation process.  
5.1.1 Hard and soft protein corona  
 Due to their high free energy, ENM surfaces in contact with biological media are 
rapidly covered by biomacromolecules that form a corona. In blood the coating is 
proteins, in lung it might be surfactants, and in the environment it might be natural 
organic matter. Focusing on blood, the adsorption of proteins on the surface of 
nanoparticles is governed by protein–nanoparticle binding affinities and protein–protein 
and protein-NP interactions. Proteins with high binding affinity that are tightly adsorbed 
to nanoparticle surfaces are referred to as the “hard” corona.  The hard corona therefore is 
typically believed to consist of a single protein layer coating the nanoparticle surface.   
More loosely bound proteins with low binding affinity to the nanoparticle may be 
connected through weak protein-protein interactions and are referred to as the “soft” 
corona (Figure 5.1).166-167 Generally, the hard corona is believed to consist of proteins 
that show irreversible protein binding to the nanoparticle or very low protein exchange 
rates.168 The soft corona is thought to have high exchange rates and can be easily replaced 
through competition with other biomolecules in a given biological environment.168-170 
Over time, proteins that have a higher affinity for the ENM should predominate to form a 
more stable corona similar to the Vroman effect of small molecule protein adsorption.  
There is some evidence that the hard protein corona may be responsible for directing cell 
recognition and the subsequent interaction pathways for some nanomaterials.166 Due to 
the transient nature of the soft corona, usually there is little to no information gained 
about the possible role of the soft corona on NP-cell interactions.  Indeed, to date there is 
still very little known about the true biologically relevant corona composition due to the 
difficulties of identifying the soft corona in vivo.168 
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Figure 5.1 Schematic illustration of hard and soft corona formation on the surface of 
nanoparticle. Forming the hard corona involves the interactions of the binding proteins to 
the nanoparticle surface. The soft corona is dictated by weaker protein-protein 
interactions as free protein binds to the protein coated nanoparticle. The hard and soft 
coronas are not typically composed of one type of protein but a mixture of proteins 
whose exact composition depends on multiple variables. 
 
 
5.1.2 The biological impact of the protein corona 
 The nature of ENM coronas is determined by interactions with local environments.  
These interactions are dynamic and rapid; their time course is poorly understood. The 
long residence times of the hard corona suggests these proteins remain adsorbed on 
ENMs even through processes such as transport through the blood or cell endocytosis. 
Proteins may adsorb and detach at any time suggesting a corona composition that 
changes over time in response to its biological environment.  This is consistent with the 
‘Vroman effect’ that suggests while the total amount of adsorbed protein may remain 
constant, the exact composition may change over time. We may imagine therefore that 
the corona composition depends not only on the current biological fluid the ENM is 
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exposed to as it traverses the body but potentially on all the environments the ENM has 
moved through.  Little is known about these exchange dynamics but if it is slow, relative 
to the particle pharmacokinetics, the corona may retain proteins from their previous 
environments while travelling to different locations within organisms.163, 171-172  
 
 Internalization, biodistribution and cell response to nanoparticles in vivo have been 
posited to be most critically affected by the composition of the hard corona. For example, 
the adsorption of certain proteins, such as IgG and fibrinogen, has been shown to allow 
macrophages to recognize the nanoparticles more easily and promotes early inflammation 
and clearance from the system.173-174 Alternatively, adsorption of albumin has been 
reported to reduce adhesion of the nanoparticles to cell membranes and promote 
prolonged circulation times in the blood.175-177 Others report that the binding of specific 
proteins may allow for the targeted delivery of nanoparticles. For example, the adsorption 
of apolipoprotein E on the surface of nanoparticles has been utilized for improving the 
distribution of nanoparticles across the blood brain barrier (BBB) thus enabling potential 
drug delivery to the brain.178 
 
 People are still debating on the benefits or disadvantages of the protein corona.179 In 
some cases, protein binding can be used to direct delivery or target the nanoparticle to a 
particular area of the body and even trigger the nanoparticle-cell recognition or initiate 
alternative cell signal transduction.180-181 However, the formation of protein corona also 
can cause the premature clearance of nanoparticles or the rapid accumulation of NPs into 
the liver and spleen thus increasing the risk of toxicity.179 It has been shown that, in some 
cases, the cytotoxicity of nanoparticles can be mitigated by the presence of a protein 
corona that protects cells from direct exposure to bare nanoparticle surfaces.182-183 The 
immune cell response can also be activated depending on the type of corona formation.184 
For example, when NPs are exposed to blood, the plasma corona formation can mark 
nanoparticles as antigens and promotes phagocytosis to elicit an immune response. Here, 
the protein corona promotes the immunotoxicity by causing inflammation and damage to 
the host.185-187 Considering the biosafety of ENMs, we believe that a deep understanding 
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of protein corona formation and kinetics is vital to predicting effect on physiological 
systems and regulating the resulting immune responses and cell toxicities.  
 
5.1.3 Model proteins: bovine serum albumin (BSA) and human transferrin (Tf) 
 Nanoparticles for different biomedical applications are commonly given via 
intravenous administration. This route results in pristine or treated NPs being first 
exposed to blood after IV injection.   The complete human blood-plasma proteome may 
contain as many as 3700 different proteins with 12 order of magnitude difference in their 
concentrations.164, 188 Among these thousands of proteins, serum albumin is the most 
abundant protein accounting for ~ 60% of total proteins in blood plasma.189 Many 
researchers have demonstrated that serum albumin can interact with various 
nanomaterials and affect cellular-level events, including nanoparticle binding, 
internalization, and transport.166, 181, 190-192 Therefore, we chose bovine serum albumin 
(BSA) as one of our model proteins to investigate in our experiments. 
 
 We also chose to study human transferrin (Tf) as our second protein model. 
Transferrin is an abundant human plasma glycoprotein which has a molecular weight of 
around 80 KDa and contains two specific high-affinity Fe3+ binding sites.193 It binds to 
the Tf-receptor (TfR) in iron-bound form and activates receptor mediated endocytosis to 
control the level of free iron in cells.194 It has been reported that tumor cells have a higher 
demand for iron and generally overexpress the TfR.  Although the precise cellular 
mechanism is not clear, it is known that transferrin can increase delivery of nanoparticles 
across the blood-brain-barrier (BBB) through receptor mediated transcytosis of Tf-TfR.  
Therefore Tf has been widely used to functionalize many nanomaterials for site-specific 
drug delivery and cancer treatments.195-197  
 
5.1.4 Research motivation 
 Since the composition and kinetics of protein adsorption on nanoparticles are likely to 
be important biologically to transport process and cellular responses, a detailed 
characterization of the formation and kinetics of protein corona formation is necessary to 
understand the beneficial applications and risks.179, 198 As new information is gained 
about the pharmacokinetics of ENMs in vivo, understanding the kinetics of corona 
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formation and exchange is even more critical.  The formation of protein corona can be 
determined by a variety of parameters such as particle size, surface charge, colloidal 
stability of NPs, as well as type of proteins.167, 198-201 However, the knowledge of protein 
corona is still far from comprehensive. To gain sufficient knowledge on this complex 
topic, huge datasets are required. Moreover, many studies were done on very unique 
systems which are sufficiently different from each other as to not allow for easy 
comparison.202 Therefore, we need new methods to quantitatively determine the 
equilibrium and kinetic parameters of protein corona formation. 
 
 Corona formation is a dynamic process and there are continuous protein association 
and dissociation events before reaching binding equilibrium. Understanding the time 
evolution of the protein corona formation in a given biological fluid, enables predictions 
of the life time and biological fate of nanoparticles.203 Compared to the study of 
characterization of protein corona, relatively little work has been done on determining the 
kinetics of corona formation. Many studies use “immediately”, ”rapidly” or “ several 
minutes to several hours” to describe the time-scale on corona formation.161-162, 204 This 
may be due to the limitations of most methods that have not allowed for time-dependent 
analysis.  
 
 Many techniques used to measure the protein corona are ex situ and require isolation 
of the nanomaterial with its bound protein from the physiological environment165. 
Isolation is typically performed using either differential centrifugation (DC) or size 
exclusion chromatography (SEC).  It is believed that isolation biases subsequent analysis 
towards the hard corona and removes evidence of the soft corona. The quantitative 
identification of adsorbed proteins on the nanoparticle surface is often performed by 
using poly(acrylamide) gel electrophoresis (PAGE) followed by mass spectrometry. By 
using these methods, samples have to be treated with high temperatures, high salt 
concentrations, detergents, and enzymes and thus make the proteins under the risk of to 
be denatured.165, 169, 188  
FCS is a powerful method for the in situ study of protein corona formation without 
some of the shortcomings of other methods. FCS allows for measurements under diluted 
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NP concentration more representative of in vivo conditions. Another advantage of FCS is 
that measurements can be carried out in situ without separation of unbound excess 
proteins from the system and thus measurements in real equilibrium are possible.202 By 
using FCS, the precise fractions of protein-NP complex and unbound protein are 
provided which allow us to characterize both the thickness and density of protein corona 
based on the stoichiometry ratio. FCS also enables us to continuously track the evolution 
of protein corona on the ~minute time scale after nanoparticles are introduced into a 
protein solution. In this manner, we can monitor the change in bound protein fraction as a 
function of exposure time in protein solutions. These measurements can also be carried 
out under different conditions to study how physiological environments influence the 
kinetic parameters of corona formation.  
It is not easy to investigate the fundamentals of binding processes with a complex 
mixture of proteins, such as blood plasma where competitive adsorption may occur. It is 
therefore instructive to use more model systems to examine protein binding to NPs.  In 
this chapter, we will examine protein adsorption to 50 nm diameter sulfonated 
polystyrene (PS) beads in solutions containing simply buffer and one protein (serum 
albumin (BSA) or human transferrin (Tf).  Using these simple model conditions, we can 
establish the binding profile for specific proteins with high affinity.  Comparable to 
previous studies, we show the formation of multi-layered protein coronas on PS beads 
and compare the corona formation to established adsorption models. The thicknesses of 
these coronas are dependent not only on concentration but the identity of the adsorbing 
protein.  To the best of our knowledge, we also for the first time measured by FCS the 
protein binding kinetics as a function of pH and salt. Our results show that BSA 
adsorption kinetics is only slightly affected by either pH or salt.  In contrast, Transferrin 
shows significantly enhanced protein binding rates with decreasing pH.  In addition, we 
show that though the rate of binding is unaffected by salt, the binding affinities for BSA 
and Tf are greatly enhanced by the presence of additional salt.  These results begin to 
shed light on how coronas are formed on nanomaterials under different conditions.  
Through these studies, we aim to gain quantitative knowledge of the dynamic 
rearrangement of proteins on engineered nanomaterials.  Such studies can also be used to 
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guide our biophysical modelling of the in vivo conditions for corona formation to 
engineer optimized nanoparticles for biomedical applications. 
 
5.2 Materials and Methods 
	
5.2.1 Sample preparation 
 Polystyrene latex beads, sulfonated modified PSOSO3H (nominally 50 nm) were 
purchased from Polysciences Inc. (Warrington, USA). Purified fluorescently labeled 
proteins: Alexa488 conjugated Human transferrin (Tf) and Alexa488 conjugated bovine 
serum albumin (BSA) were purchased from Invitrogen by Life Technology (Carlsbad, 
CA). Unlabelled proteins were dissolved with 1x PBS (Sigma Aldrich (St. Louis, MO)) 
into 1mg/ml stock solutions as recommended by the supplier and then further diluted to 
the required concentration/buffer conditions as needed.  For protein-nanoparticle binding 
equilibrium experiments, polystyrene beads were added into protein solutions and 
equilibrated for at least one hour before measurements. To study the kinetic of binding, 
the measurements started right after the polystyrene beads were mixed into protein 
solutions. 
 
5.2.2 FCS setup and data analysis 
 FCS experiments were made using an ISS Alba confocal fluorescence fluctuation 
system coupled to a Nikon Ti-U microscope equipped with a 60×1.2 NA water 
immersion objective lens. The illumination source was a continuous-wave 488 nm laser 
diode. The emission signal for the 488 nm was passed through a 514 nm long-pass edge 
filter before detection. Emission signal was recorded by two separate photomultiplier 
tubes (PMTs). All FCS measurements were performed in NUNC LabTek 8-well 
microscopy chambers with a final volume of ~500 µL.  Determination of the focal 
volume was established via calibration against an aqueous solution of rhodamine 110 (D 
= 440 µm2 s-1).  FCS results are an average of at least 20 measurements with typical 
sampling times of 30-60 s. All results are expressed as the mean ± SD of the measured 
diffusion coefficient. FCS measurements were analyzed using VistaVision 4.0 software.   
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3D-Gaussian one-component and two-component fitting models, as described in chapter 
2, were used for data analysis. 
 
The basic principles of FCS are described in detail in chapter 2.  Here we give just a 
brief overview.  The measured signal in FCS is the fluorescence intensity I(t) emitted by 
the observed particles moving in and out of a small, femotliter illumination volume. The 
size of the effective illumination volume is fixed by the confocal optics and the excitation 
profile of the focused laser beam is characterized by measurements against a standard of 
a known diffusion constant. For ideal particles of uniform size diffusing by Brownian 
motion, dynamic information can be determined from the intensity fluctuations by means 
of a time autocorrelation given by  
𝐺(τ) = !
!
(1+ !
 τ!
)!!(1+ !!!
!!
!
!!
)!/!.                                           (1) 
Here, N is the average number of particles in the illumination volume and the structure 
parameters r0 and z0 are the axial and radial dimensions of the excitation beam 
determined by calibration measurements against a known standard.  
 To determine the fractions of unbound protein and protein-NP complex, a two-
component fitting model is applied to analyzing the measured autocorrelation function. 
As only the protein is labeled, fluorescence observed from both the fast and slow 
components come from the same dye.  The quantum yield term can thus be cancelled and 
the equation can be simplified to: 
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where 𝜏!! 𝑎𝑛𝑑 𝜏!! are the independent translational diffusion times of fast (free protein) 
and slow (protein-NP complex) components crossing the illumination volume. 𝜔 is the 
structure parameter equal to the ratio of 𝑟! 𝑎𝑛𝑑 𝑧!. α is the fraction of particles with 
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slower diffusion time (τD2) of the total number of fluorescent particles which is expressed 
as N. The autocorrelation can then be normalized by  
 
𝐺!"#$. 𝜏 =
! !
! !
        (3) 
 
The total number of protein molecules in the FCS confocal volume is 𝑁!"!#$ = 𝑁!"## +
𝑁!"#$%  where we assume that each observed NP has at least one fluorescently labeled 
protein bound and that quenching of chromophore on PS beads is insignificant. The 
fraction of bound protein can be expressed as 
 
        𝛼 = !!"#$%
!!"!#$
         (4) 
 
 To compare the protein corona formation in different systems, we focused on the 
normalized fraction of bound protein and defined it as  
 
𝑓 =
1        if 𝑥 ≤ 𝑥!∗
!!∗
!
     if 𝑥 > 𝑥!∗
        (5) 
 
where x represents the molar ratio of protein to nanoparticles that x = [protein]/[NPs]. xc* 
is the critical molar ratio of a saturated monolayer coverage; in other words, the average 
number of proteins required to form a single monolayer (hard corona) per nanoparticle.  
 
 
5.3 Results and discussion 
	
5.3.1 Formation of hard and soft corona layers 
 Before examining the kinetics of protein corona formation, we first examined the 
equilibrium formation of a protein corona on our nanomaterials.  Two Alexa488 labeled 
proteins, bovine serum albumin (BSA) and human transferrin (Tf), were examined by 
FCS for their ability to form protein corona layers on 50 nm diameter sulfonated 
polystyrene (PS) beads. The adsorption of protein is detected by a change in the diffusion 
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coefficient of protein bound to the NP and the fractions of free proteins and bound 
proteins are determined by a two-component fit to the time autocorrelation function from 
FCS. One unique aspect of FCS is that it not only provides information about 
hydrodynamic size but also gives information related to the average number of 
fluorescent-labeled particles or proteins in solution.  Figure 5.1A shows FCS 
autocorrelation curves for BSA at four PS concentrations. The amplitude of the time 
autocorrelation G(0) is inversely proportional to the number of fluorescent species, N and 
thus concentration. With increasing PS bead concentration, G(0) increases while 
simultaneously shifting to larger values for the dwell time (τ) or diffusion time of the 
particle.  At each concentration, samples were mixed thoroughly and allowed to 
equilibrate for at least one hour.  Since all the samples were made with the same initial 
Alexa488-BSA concentration, the sharp increase in the amplitude, G(0), of the 
autocorrelation curves indicated a significant decrease in the measured number of labeled 
particles due to adsorption to the PS beads. The increase in the observed diffusion time to 
larger values is best seen in the normalized autocorrelation curves shown in Figure 5.1B.   
 
Without the PS nanoparticles in the system, the autocorrelation of free protein is well 
described by a one component fit with a single mean dwell time, τ. In the presence of PS 
beads, measured autocorrelation functions are best described by a two-component fit 
where the fast component (free protein) is fixed at the experimentally determined value. 
This two-component fit to G(τ) allows us to directly quantify the fractions of slow 
(protein-NP complex) to fast (free protein) in solution.  Experimentally the slow fraction 
was observed to be near constant diffusion time and consistent with the measured 
hydrodynamic radius of a fully coated PS bead by DLS.  Diffusion times for both the 
slow and fast fractions were therefore fixed to these values and only the ratio of slow/fast 
was allowed to vary in the plotted fits (solid lines).  
 
Similar results are observed for Tf binding to the same 50 nm PS nanoparticles. The 
experimentally determined autocorrelation functions and normalized autocorrelation 
functions for Tf-PS at varying PS concentrations are shown in Figure 5.2A and 5.2B, 
respectively. 
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Figure 5.2 (A) Autocorrelation functions of BSA binding to 50 nm diameter PSOSO3H 
NPs in DI water at different NP concentrations. Four NP concentrations are shown. Solid 
lines represent the best fits from a two-component model described by equation 2. (B) 
Normalized autocorrelation curves of BSA-NP exhibit a systematic shift to longer 
correlation times indicating an increasing fraction of bound protein with increasing NP 
concentration. 
 
 
(A)	
(B)	
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Figure 5.3 (A) Autocorrelation functions of Tf binding to 50 nm diameter PSOSO3H NPs 
in DI water at different NP concentrations. Solid lines represent the best fits from a two-
component model described by equation 2. (B) Normalized autocorrelation curves of Tf-
NP exhibit a systematic shift to longer correlation time indicating an increasing fraction 
of bound protein with increasing NP concentration. 
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 The two component fit to G(τ) allows us to quantify the amplitude of the slow (bound) 
and fast (free) component in the data and thus determine the fraction of bound proteins in 
solution. To improve the robustness of the fitting, the diffusion time of free protein and 
the size of fully coated protein-PS complex are kept as fixed parameters. The τD is related 
to the translational diffusion coefficient D by the simple relationship 𝐷 = !!
!
!!!
. The 
diffusion coefficients of free BSA and Tf as determined by FCS were 68.4±6.1 µm2/s and 
59.6±6.2 µm2/s. The corresponding hydrodynamic radius calculated from Stokes-Einstein 
equation are 3.4±0.3 nm and 3.9±0.4 nm; in good agreement with the values obtained for 
BSA and Tf by dynamic light scattering (DLS).205-206 Likewise, the calculated 
hydrodynamic radius of nanoparticles fully covered with proteins are in good agreement 
with the protein coated nanoparticles measured by DLS. All the relevant values are listed 
in Table 5.1 for comparison. 
 
Table 5.1 Measured hydrodynamic radius (rh) of free proteins and protein-NP complexes 
by FCS and DLS. The first row shows the hydrodynamic radius of the commercial 
Polystyrene (PS) beads, the unlabeled BSA and Tf as well as protein-PS complexes 
measured by dynamic light scattering (DLS). The second row gives the corresponding 
values as determined by FCS. The free protein rh values marked by * are reported values 
from the literature.205-206   
 
rh (nm) PS-50 BSA Tf BSA-PS Tf-PS 
DLS 24.4±0.9 3.48 * 3.72* 27.5±0.4 29.7±0.5 
FCS N/A 3.4±0.3 3.9±0.4 28.1±2.6 30.8±3.3 
 
 
 Next, we examined the fraction protein bound, f, as a function of the PS bead 
concentration.  Figure 5.3 shows the normalized fraction of bound protein as a function of 
nanoparticle (PS) concentration for two BSA protein concentrations.  Figure 5.4 shows 
similar measurements for Tf measured at the same two protein concentrations.  As 
expected with increasing NP concentration, the fraction of bound protein, f, increases 
reaching a plateau of 100% bound at a critical NP concentration.  However, the 
adsorption is seen to depend on the amount of protein present with more nanoparticles 
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required to bind all the proteins in solution for samples with higher initial protein 
concentration.  The dashed lines in Figure 5.3 and 5.4 represents best fits to the 
experimental data assuming a Langmuir adsorption isotherm. This model is used to 
describe the adsorption equilibrium with the assumption that each binding site is 
equivalent to all the adsorbate.  This behavior is also referred as the Hill equation in 
biochemistry. The protein adsorption to nanoparticle surface can be modeled by a 
Langmuir isotherm given as207 
 
𝑁 = 𝑁!"# ∙
1
1+ ( 𝐾!
!
𝑐 𝑃 )
!
 
 
Here, Nmax is the maximum number of proteins binding to the nanoparticle. c(P) is the 
concentration of free protein. K’D is the dissociation constant. n is the Hill coefficient. In 
this interpretation, the Hill coefficient describes how the bound proteins influence the 
adsorption of further free protein onto the same nanoparticle. When the Hill coefficient, 
n > 1, proteins already bound to a nanoparticle facilitate the binding of further proteins to 
the remaining vacant site.  This is described as cooperative binding. When n < 1, the 
bound proteins lower the tendency for additional proteins to bind and is described as anti-
cooperative binding.202 The results of our fits have n > 1 for Tf-PS but n < 1 for BSA-PS 
system (Table 5.2) indicating that BSA and Tf may undergo different adsorption 
mechanism to the sulfonated PS bead surface.  
 
Table 5.2 Hill coefficients of protein adsorption isotherms (at different initial protein 
concentrations) fit by Hill equation (Langmuir isotherm). 
 
Hill coefficient BSA (2.5 µg/ml) BSA (20 µg/ml) Tf  (2.5 µg/ml) Tf (20 µg/ml) 
n 0.85 0.95 1.4 1.7 
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Figure 5.4 Normalized bound BSA protein fraction, f, determined by FCS measurements, 
as a function of increasing PS bead in DI water. Experiments were performed at two 
fixed concentrations of BSA. Dashed lines are best fits to a Langmuir adsorption 
isotherm.  
 
 
Figure 5.5 Normalized bound Tf protein fraction, f, determined by FCS, as a function of 
increasing PS bead in DI water. Experiments were performed at two fixed concentrations 
of Tf. Dashed lines are best fits to a Langmuir adsorption isotherm.  
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 In Figure 5.5 and 5.6, the normalized bound fraction f is equal to 1 up to the critical 
molar [protein]/[NP] value indicative of full surface coverage and consistent with a 
strong binding model of protein to NP. Above the saturation concentration (𝑥!∗), f 
decreases due to the presence of unbound protein.  We note that the bound fraction does 
not decrease as rapidly as predicted for a simple strong binding model indicating that at 
higher protein/NP concentrations more than a single monolayer of protein is binding to 
the nanoparticles. 𝑥!∗  represents a protein concentration sufficient for a complete 
monolayer formation on the nanoparticles for a given system.  This concentration will be 
used later for kinetic studies. We determined 𝑥!∗ ~110 proteins per bead for BSA-PS and 
~130 proteins per bead for Tf-PS. A 50 nm diameter PS bead has a surface area of 
roughly 7900 nm2. The surface area occupied by each protein can be estimated by 
knowing 𝑥!∗. From the determination of 𝑥!∗, we can estimate that a single BSA protein 
occupies about 71 nm2 on the surface of PS while Tf occupies about 60 nm2. These 
values are slightly larger than the surface area of bare protein (BSA=50 nm2, Tf=42 
nm2)168, 190 as estimated from their structure in solution.  
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Figure 5.6 The normalized fraction of bound protein, f, as a function of ratio of BSA to 
NPs. The vertical dash line indicates the ratio of full surface coverage which is around 
110. The solid line is the simple single layer strong binding curve. 
 
 
Figure 5.7 The normalized fraction of bound protein, f, as a function of ratio of Tf to NPs. 
The vertical dash line indicates the ratio of full surface coverage which is around 130. 
The solid line is the simple single layer strong binding curve. 
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 To characterize the thickness of protein corona, we use the model described 
previously by Milani et. al.168 In Figure 5.7 and 5.8, we plot the surface coverage Γ as a 
function of the molar ratio of proteins to nanoparticles for BSA and Tf respectively. Γ 
represents the number of protein molecules bound per nanoparticle and is calculated from 
the measured fraction of bound proteins from FCS and the known total number of 
proteins per NP as  
 
𝛤 =
Tf
NPs
                   if 𝑥 ≤ 𝑥!∗
Tf 𝑓 − 𝑓!"
NPs
     if 𝑥 > 𝑥!∗
 
 
where f is the fraction bound from experimental data. fHC is the calculated fraction bound 
to saturate the monolayer ‘hard’ corona from the known saturation concentration (vertical 
dash line). The horizontal dash lines indicate the theoretical number of proteins in each 
corona layer calculated from the known surface area of the PS bead and the occupation 
area of each protein molecule. We observe for both BSA and Tf the tendency to form 
multi-layer coronas on the PS nanoparticles.  This is an estimate and it should be noted 
that the adsorption of proteins may be more heterogeneous than assumed in this model. 
The existence of multi-layer protein coronas on PS beads has been reported previously as 
measured by other methodologies such as AFM.208 
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Figure 5.8 Surface coverage, Γ, in number of BSA molecules bound per NP. The number 
of BSA bound beyond full coverage was inferred from experiments by subtracting the 
hypothetical first monolayer of molecules.  Theoretical surface coverage for BSA 
molecules per layer calculated from the known bead surface area and occupation area per 
BSA molecule are given by the horizontal dashed lines. 
 
 
Figure 5.9 Surface coverage, Γ, in number of Tf molecules bound per NP. The number of 
Tf bound beyond full coverage was inferred from experiments.  Theoretical surface 
coverage for Tf per layer calculated from the known bead surface area and occupation 
area per Tf protein are given by the horizontal dashed lines. 
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5.3.2 The kinetics of protein corona formation 
 For kinetic studies, we will focus on conditions sufficient to form a complete 
monolayer of protein per molecule; i.e. 𝑥!∗ for a given protein-NP system. Figure 5.9 
shows the normalized autocorrelation functions of Alexa488-Tf as a function of exposure 
time with the 50 nm sulfonated PS nanoparticles. The curves clearly shift to longer 
diffusion times due to protein-NP complex formation as a function of the incubation time.  
The complex formation occurs on a time scale on the order of minutes and is readily 
resolved by FCS. Similar results were observed for BSA-PS complex formation. 
 
Figure 5.10 Normalized autocorrelation curves of Alexa488-Tf at different incubation 
times after adding PS nanoparticles. 4 µg/ml Tf was mixed with PS under 130:1 molar 
ratio in 1mM MES buffer. The black curve represents the free Tf solution before adding 
PS. The blue, green and red curves represent the measurements at 5, 10 and 30 mins after 
adding PS, respectively.  
 
 The dynamics of protein binding reactions can be affected by various parameters.  
First we examined the binding kinetics as a function of protein concentration.  Under the 
conditions of FCS, we are most sensitive at low ~nM concentrations of protein, so we 
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focused on lower protein concentrations equivalent to 1x, 2x, and 3x the saturated molar 
protein/NP concentration (𝑥!∗) determined for the protein.  From the results shown in 
Figures 5.10 and 5.11, we see the duration to reach binding equilibrium (where f=1) has 
little dependence on the protein concentration in this concentration regime.  Figure 5.11 
may suggest Tf-PS binding kinetics has a weak concentration dependence, especially 
compared to BSA-PS (Figure 5.10) which shows almost no change.  As will be shown 
below, this weak dependence is minimal compared to the dependence of the binding 
kinetics for other parameters such as pH and salt.   
 
 
Figure 5.11 Concentration dependence of the fraction of bound protein, f, as a function 
of incubation time for BSA-488 interacting with PS beads. BSA was mixed with PS at 
molar ratios equivalent to 1x, 2x, and 3x the saturated [protein/NP] concentration (𝑥!∗) 
determined previously. 
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Figure 5.12 Concentration dependence of the fraction of bound protein, f, as a function 
of incubation time for Tf-488 interacting with PS beads. Tf was mixed with PS at molar 
ratios equivalent to 1x, 2x, and 3x the saturated [protein/NP] concentration (𝑥!∗) 
determined for Tf-PS previously. 
 
 
5.3.3 pH and salt effect on protein binding rate and binding affinity 
 The polystyrene nanoparticles used in this study are sulfonated and known to contain 
a slight anionic charge from sulfate ester terminal groups (PSOSO3H) which helps 
prevent agglomeration and maintain the beads in aqueous solution. The degree of 
protonation of the PS terminal groups can thus change the surface chemistry of the PS 
beads and the interactions with proteins. To examine the effects of surface charge, we 
measured in Figures 5.12 and 5.13, the BSA and Tf fraction of bound protein, f, as a 
function of low concentrations of MES (pH 6.4) buffer. We believe in this buffer 
concentration range (10 µM to 1 mM), we are spanning a range from only partial 
buffering of the NP solution to a more complete buffering of the NPs. BSA and Tf have 
similar net protein charge and both are slightly negative.  BSA does differ from Tf in 
being a fairly hydrophobic protein and is known to strongly bind to hydrophobic 
surfaces.209-211   For the hydrophobic BSA protein, the binding rates to PS do not change 
significantly over this buffer concentration range.  There is a slight shift to faster 
adsorption (~75 mins to 60 mins) by 1 mM MES vs. 10µM MES.  In contrast, the binding 
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of Tf to PSOSO3H changes dramatically over this buffer concentration range. At 𝑥!∗, in 
10 µM MES, the formation of the hard corona takes approximately 50-60 minutes similar 
to what we observe in DI water.  Increasing the MES concentration to 100 µM and 1 mM 
greatly increasing the binding kinetics to ~20 and 10 minutes respectively.  Under these 
conditions, both Tf and BSA are negatively charged since their pI are 6.1 and 4.7, 
respectively.212-213   Due to the pKa of the proteins, we would not expect the buffer to be 
significantly modifying the charge of the protein.  Therefore, we speculate that this 
concentration of buffer is sufficient to modify the PSOSO3H surface charge resulting in 
significantly faster protein corona formation.  We hypothesize that the hydrophobic BSA 
is more attracted to the hydrophobic PS surface and less influenced by the small changes 
in surface charge caused by the MES buffer. 
 
 
Figure 5.13 The fraction bound of BSA, f, as a function of incubation time with PS NPs 
in thee different concentrations of MES buffer (pH 6.4). BSA-488 was mixed with PS 
NPs at the critical molar ratio (𝑥!∗) with a sufficient concentration of protein to form the 
hard corona monolayer.  
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Figure 5.14 The fraction bound of Tf, f, as a function of incubation time with PS NPs in 
three concentrations of MES buffer (pH 6.4). Tf-488 was mixed with PS at the critical 
molar ratio (𝑥!∗) for a sufficient concentration of protein to form the hard corona 
monolayer.  
 
 Changing buffer concentration over this range may be effecting the ionic strength 
concentration of the solution.  To disentangle the role of pH and salt, we examined the 
protein corona formation kinetics for the same concentration of two different buffers and 
a neutral pH NaCl salt solution. Again all these experiments were performed at the 
critical molar concentration 𝑥!∗  where there is sufficient protein to form a single 
monolayer on all the PS nanoparticles present. These results are shown in Figures 5.14 
and 5.15.  Protein binding to PS was examined at 100 µM solutions of MES (pH 6.4), 
PBS (pH 7.4) and NaCl solution (pH 7).  For the hydrophobic BSA, all three sample 
conditions showed similar protein corona formation kinetics (Figure 5.14).  For Tf, 
however, we see a significant shift to a much faster equilibrium binding time only at low 
pH.  Tf binding to PS is nearly identical in buffered pH 7.4 solution as in 100 µM neutral 
NaCl salt solution.  These results indicate the increase in the rate of protein binding at 
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this buffer concentration is most likely not due to ionic strength effects but rather due to 
modifications of the PS surface charge at low pH. 
 
Figure 5.15 The bound protein fraction of BSA, f, as a function of incubation time with 
PS NPs at the critical molar ratio (𝑥!∗) to form monolayer corona.  
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Figure 5.16 The bound protein fraction of Tf, f, as a function of incubation time with PS 
NPs under the critical ratio (𝑥!∗) to form a monolayer corona.  
 
 
 In addition, we examined the effect of added salt at neutral pH on protein binding 
kinetics to our sulfonated PS beads.  Low salt concentrations must be used as higher salt 
concentrations lead to an aggregation of the PS beads even in the absence of protein.  
Again, PS nanoparticles were incubated with the experimentally determined critical 
molar concentration (𝑥!∗) sufficient to form a monolayer corona.  Protein binding kinetics 
was examined at three NaCl salt concentrations ranging from 0 to 1 mM added salt.  The 
normalized protein binding fractions, f, as a function of incubation time are shown in 
Figures 5.16 and 5.17, for BSA-PS and Tf-PS respectively.  Similar to previous results, 
we see no significant change in the binding kinetics for these protein-PS systems over 
this salt concentration range.  Salt does not appear to make the protein binding any faster; 
the protein-PS samples appear to reach the equilibrium of hard corona formation at equal 
rates.  Although the rate of protein binding is not affected by the ionic strength, when we 
look at the nominal fraction of bound protein (α) determined by FCS we see that the 
fraction of bound protein under these [protein]/[NP] concentrations is highly dependent 
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on salt.  This is shown for BSA-PS and Tf-PS in Figures 5.18 and 5.19.  This indicated 
that the protein binding affinities for PS are altered with the addition of added salt.  Again, 
the effect of salt is significantly less for the hydrophobic BSA protein compared to the 
more hydrophilic Tf protein. Over this NaCl salt concentration range, we see the absolute 
amount of BSA increase from ~46% to 55% bound at 𝑥!∗.  In contrast, total Tf binding to 
PS increases from 60% to nearly 100% at 1 mM added NaCl.   
 
 
Figure 5.17 The fraction bound of BSA, f, as a function of incubation time with PS NPs 
under the critical ratio (x*) to form monolayer corona. The experiments were performed 
in pure deionized water and salt solutions with different concentration at pH=7.0. 
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Figure 5.18 The fraction bound of Tf, f, as a function of incubation time with PS NPs 
under the critical ratio (x*) to form monolayer corona. The experiments were performed 
in pure deionized water and salt solutions with different concentration at pH=7.0. 
 
  
Figure 5.19 The FCS measured fraction of bound BSA (α) as a function of incubation 
time with PS NPs under the critical ratio (𝑥!∗) to form a monolayer corona. The 
experiments were performed in pure deionized water and salt solutions with different 
concentration at pH=7.0. 
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Figure 5.20 The FCS measured fraction of bound Tf (α) as a function of incubation time 
with PS NPs under the critical ratio (𝑥!∗) to form a monolayer corona. The experiments 
were performed in pure deionized water and salt solutions with different concentration at 
pH=7.0. 
 
 We hypothesize that the binding of BSA, a hydrophobic protein, to PS nanoparticles 
is driven primarily by the hydrophobic protein-NP interactions.  Despite being slightly 
sulfonated, it is reasonable to assume that much of the PS bead surface is fairly 
hydrophobic similar to bulk PS. As this interaction dominates, the binding kinetics of 
BSA to PS is nearly independent of the pH or salt consistent with our experimental 
results.    It is known that Transferrin is capable to reversibly bind with ferric irons and 
this binding process is very sensitive to the pH of the surrounding. It has been reported 
that the affinity of transferrin for Fe3+ is extremely high	 	 (1023 M−1) at pH 7.4 but iron 
begins to dissociate from transferrin at acidic pH (pH = 6).214-215 Moreover, the processes 
of binding and releasing Fe3+ are associated with a significant conformational change in 
the 3D structure of transferrin.216-217 Control of the Tf-PS interactions appears to be 
governed by the electrostatics in the system and results in a significant increase in the rate 
of corona formation.  As Tf, like our PS beads, has a slightly negative charge, a reduction 
	 108	
in the charge of the PSOSO3H bead surface with low pH may explain the increased 
kinetics.  This may be the result of an increased hydrophobicity of Tf at low pH.  We also 
hypothesize that corona formation may follow a multi-step process where there is first an 
approach of the protein to the NP followed by a second slower step, or ‘hardening’, 
where the protein binds in a nearly irreversible manner forming the hard corona. We see 
an increase in the binding affinity, but not binding kinetics, for both systems as a function 
of added salt.  The added salt concentrations are low and not expected to significantly 
alter the Debye screening length of the PS bead.  This increase in binding kinetics may 
then suggest that the process of hardening is enhanced by the presence of the added salt 
resulting in a much higher affinity for the protein to the bead.   
   
5.4   Conclusion and future perspective 
 In this study, we investigated the protein corona formation and the binding kinetics of 
two proteins (BSA and Tf) to 50 nm sulfonated PS beads by FCS. We characterized both 
the complex size and corona thickness for these systems.  Our results, consistent with 
previous results on 100 nm PS beads, show multilayer corona formation consisting of 
both a hard and soft corona.  Total corona thickness was dependent on the protein with 
BSA forming a thicker soft corona layer compared to Tf at equivalent [protein]/[NP] 
concentrations.  More importantly, we were able to measure the kinetics of the protein 
corona formation process for both protein-PS systems.  Our results show that the binding 
rate of Tf to PS can be enhanced significantly at lower pH.  BSA-PS binding rates were 
not strongly affected by solution pH.  Added salt for both protein-PS systems did not 
significantly change the binding kinetics; however, the binding affinities of the protein 
were greatly enhanced even at relatively low (≤ 1 mM) added NaCl salt concentration.  
Tf-PS binding was especially sensitive with nearly 100% binding affinity achieved at 1 
mM NaCl.  We hypothesize that BSA binding to PS is mostly dominated by hydrophobic 
interactions and less influenced by salt or pH.209, 211 Tf, being significantly less 
hydrophobic, shows much more sensitivity to surface binding on PS depending on the 
charge state of the surface.  This may be due to transferrin having a higher 
hydrophobicity at low pH that drives the protein adsorption.  The hydrophobicity of BSA 
is then relatively independent of the pH variation in this study.  The increased binding 
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affinities of the proteins to PS occur at salt concentrations not likely to affect Debye 
screening lengths.  This may suggest the effect of added salt is to enhance “hardening” 
processes which drives more complete corona formation under these conditions.  
 
 We have established FCS as not only a useful tool for the study of protein adsorption 
on NPs capable of distinguishing the presence of hard and soft coronas, but also as a 
means to study the dynamics of the corona formation process.  Although many qualitative 
studies of protein-NP interactions have been done in recent years, the protein adsorption 
equilibria and rates on NPs not been well characterized. There is a critical need for 
quantitative data of equilibrium and kinetic parameters of protein-ENM systems in both 
model systems and more realistic, biological-relevant systems.  This data is needed to 
develop a better understanding of underlying principles of nanoparticle-cell interactions 
in vivo.   Future studies will focus on the extension of our methodologies to metallic 
nanoparticles.  In addition, the effects of surface treatments and particle aging need to be 
explored for their impact on corona formation, corona thickness and kinetics of assembly.  
In addition, we are working with collaborators to calculate from the surface coverage 
determined by FCS if a protein mass coverage can be determined to assess the 
completeness and density of the hard corona formed under different conditions.  The 
capacity of FCS to measure dynamics in polymer or biological solutions is promising for 
looking at more realistical biologically relevant solution conditions.  Through such 
studies we may be able to guide the synthesis of chemically modified nanoparticles for in 
vivo application that mitigate undesired side effects or toxicities. 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Xiaolu Zhang 2015 
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Summary 
 
 Due to the rapid development of nanomedicine and the growing concern about the 
behavior of engineered nanomaterials (ENMs) in the body, in this dissertation we focused 
on the study of transport of nanoparticles with different hydrogel environments and the 
effects of protein intteractions with nanoparticle surface. Using fluorescence correlation 
spectroscopy (FCS), we were able to quantitatively determine the dynamics of molecular 
transport within neutral and charged hydrogels as well as monitor the kinetics of protein 
corona formation in situ.  
  In chapter 3 and 4, we investigated the role of electrostatics on the basic mechanisms 
governing the diffusion of charged probe molecules and dendrimer macromolecule inside 
model polymer networks. Our results suggest the mobility of nanoparticles in charged 
biological network is highly charge asymmetric and dependent on the properties of the 
particles such as size, structure flexibility and surface charge density. Small probe 
molecules and larger NPs that generally used as nanocarriers show totally different 
diffusion behavior within the same charged networks. Combined with simulation results, 
our study reveals the essential role of electrostatic interaction in particle transport in 
biological hydrogels, and the complexity of interaction filtering strategy in biological gels.  
 In chapter 5, we have quantitatively characterized the formation of a multi-layered 
protein corona on the surface of polystyrene nanoparticles. FCS also allowed us to probe 
the kinetics of protein corona formation in situ. Our results suggest that the thickness of 
protein corona, the assembly rate of protein-NP complex and the protein binding 
affinities on PS beads are dependent on the properties of proteins as well as the local 
physicochemical properties. These studies begins to shed light on how coronas are 
formed on ENMs under different conditions and can also be used to guide biophysical 
modeling of the in vivo conditions for corona formation to engineer optimized 
nanoparticles for biomedical applications.  
 
 
 
 
Copyright © Xiaolu Zhang 2015 
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